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Gene/Protein nomenclature  
 
 
 
Mouse/Rat 
 
In this thesis, mouse gene symbols are italicised, with only the first letter in 
uppercase and the remaining letters in lowercase (Bdnf). Protein designations 
are the same as the gene symbol, but are not italicised and all letters in 
uppercase (BDNF) according to the guidelines for mouse and rat gene 
nomenclature. 
 
Human 
 
In this thesis, human gene symbols are italicised, with all letters in uppercase 
(BDNF). Italics are not necessary in gene catalogs. Protein designations are 
the same as the gene symbol, but are not italicised, with all letters in 
uppercase (BDNF) according to the guidelines for human gene nomenclature. 
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Abstract 
 
 
Epigenetic mechanisms are critical regulators of gene expression 
underlying learning and memory formation. One of the most widely studied 
epigenetic mechanism is the methylation of DNA, and until recently, was 
regarded as stable in post-mitotic cells, such as neurons. This view has, 
however, recently been actualized, as DNA methylation was suggested to be 
dynamically regulated in a locus-specific manner upon neuronal stimulation 
and learning. Consistently, the expression of DNA methylases also appears to 
be dynamically regulated in the brain. A family of DNA demethylases, Ten-
eleven translocation (TET) proteins (TET 1, 2 and 3) mediate the conversion 
of 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC). There is 
accumulating evidence that TET proteins, and hence 5mC and 5hmC levels, 
are regulated by neuronal activity to control gene transcriptional regulation 
and memory. However, little is currently known about the mechanisms 
bringing about their dynamic regulation.  
 
The scope of the present work was to explore the modes of regulation 
of TETs in the context of neuronal activity and memory formation. Specifically, 
the implication of microRNAs (miRNAs), a class of short non-coding RNAs 
capable of modulating gene expression rapidly and reversibly, in controlling 
TET expression is investigated. The results indicate that Tet3 is preferentially 
up regulated in response to learning in vivo. Consistently, neuronal activation 
triggers increased Tet3 gene expression in vitro. Furthermore, targeted 
transcriptional analysis revealed that memory-related genes, such as Creb1, 
are sensitive to changes in TET3 levels. This suggests that activity-dependent 
TET3 regulation in the hippocampus can affect the transcriptional activity of 
genes related to learning and memory formation. 
 
miR-29b, a miRNA whose sequence is complementary to multiple sites 
in Tets 3’ untranslated transcribed regions (3’UTRs), is inversely regulated in 
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response to learning and neuronal activation. Importantly, miR-29b binds to 
the 3’UTRs of all Tets and controls their expression, though, a preference 
towards Tet3 is observed at low concentration. Overall, these findings suggest 
that miRNAs play a role in the activity-dependent regulation of TETs 
associated with learning and memory formation. 
 
Next, SAM68, a nuclear RNA-binding protein previously known to regulate 
alternative splicing, was identified as an important regulator of miR-29b 
biogenesis at the transcriptional level. In addition, Sam68 was found to be a 
target of TET3, which suggests that the expression of Sam68, miR-29b, and 
TET3 might be intricately regulated in response to neuronal activity through a 
feed-back loop.  
 
In summary, this study identifies a novel molecular pathway involving the miR-
29 cluster and the RNA-binding protein SAM68 in the regulation of the DNA 
demethylase TET3. This regulatory mechanism may contribute to the 
epigenetic control of genes underlying memory formation. 
 
 
 
 
  
	  	   	   7	  
Résumé 
 
Les mécanismes épigénétiques sont des régulateurs essentiels de 
l’expression des gènes dans le cas de l’apprentissage et de la formation de la 
mémoire. L’un des mécanismes épigénétiques le plus fréquemment étudié est 
la méthylation de l’ADN, qui jusqu’à présent, était considérée comme stable 
dans les cellules post-mitotiques telles que les neurones. Cependant, cette 
opinion a récemment été reconsidérée car la méthylation de l’ADN semblerait 
être régulée de façon dynamique au niveau de certains gènes suite à l’activité 
neuronale et l’apprentissage. L’expression des ADN méthyltransférases est 
également régulée de façon dynamique dans le cerveau. Les protéines TET 
(TET1, 2 and 3) (ten-eleven translocation) sont une famille d’ADN 
déméthylases capables d’hydroxyler une cytosine méthylée (5mC) en 5-
hydrométhylcytosine (5hmC). Des données de plus en plus nombreuses 
suggèrent que les protéines TETs, ainsi que les niveaux de 5mC et 5hmC, 
sont régulés par l’activité neuronale afin de contrôler la régulation 
transcriptionnelle et la mémoire. En revanche, les mécanismes sous-jacents à 
leur régulation sont à ce jour méconnus.  
 
Le sujet de cette dissertation est d’explorer les modes de régulation des 
protéines TET dans le contexte de l’activité neuronale et de la formation de la 
mémoire. Précisément, il s’agit d’étudier l’implication des microARNs, une 
classe de petits ARNs non codants capable de rapidement et réversiblement 
moduler l’expression des gènes, dans le contrôle de TETs. Les résultats 
indiquent que le gène Tet3 est préférentiellement surrégulé in vivo suite à 
l’apprentissage. Aussi, l’activité neuronale induit une augmentation de 
l’expression du gène Tet3 in vitro. De plus, une analyse transcriptionnelle 
ciblée a démontré que les gènes associés à la mémoire, comme Creb1, sont 
sensibles au niveau d’expression de Tet3. Ceci suggère que la régulation de 
Tet3 dans l’hippocampe en fonction de l’activité, peut conduire à la 
modification de l’activité transcriptionnelle des gènes liés à l’apprentissage et 
à la formation de la mémoire.  
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miR-29b, un microARN dont la séquence est complémentaire à plusieurs sites 
dans la région 3’ non traduites (3’UTR) de Tet3, est inversement régulé en 
réponse à l’apprentissage et l’activité neuronale. Par ailleurs, miR-29b se lie à 
la région 3’UTR des Tets et contrôle leur expression, mais présente une 
préférence pour Tet3 à faible concentration. Globalement, ces observations 
suggèrent que les microARNs jouent un rôle dans la régulation de TETs 
associé à l’apprentissage et la formation de la mémoire. 
 
Par la suite, SAM68, une protéine nucléaire se liant à l’ARN généralement 
impliquée dans le contrôle de l’épissage alternatif, a été identifiée comme un 
important régulateur transcriptionnel dans le contrôle de la biogénèse du miR-
29b. Ceci suggère que l’expression des gènes codant pour SAM68, miR-29b 
and TET3 est régulée en réponse à l’activité neuronale par le biais d’une 
boucle de rétroaction. 
 
En résumé, cette étude a permis l’identification d’une nouvelle voie 
moléculaire impliquant le microARN-29 et SAM68 dans la régulation de l’ADN 
déméthylase TET3. Ce mécanisme de régulation contribue probablement à la 
régulation transcriptionnelle des gènes nécéssaires à la formation de la 
mémoire. 
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1 Introduction 
 
1.1 Understanding memory 	  	  	  
“In order to be yourself, you have to remember who you are.” 
 
Joseph LeDoux 
 
The ability to learn, retain and recall information over time is a key 
feature of cognitive functions in mammals. In fact, learning offers us the 
possibility of acquiring new knowledge, and memory gives us the capability to 
remember past experiences and recall to mind previously learned facts, 
impressions, skills and habits.  
 
Based on its temporal persistence, memory can be classified in to short-term, 
lasting minutes to hours, or long-term, lasting days, months and even years. 
Long-term memories further include declarative memories, memories of facts 
and events, places and objects; and non-declarative memories, memories 
involved in perceptual and motor skills. These two types of memory also differ 
with regard to the brain regions involved. Whereas declarative memory mostly 
depends on the hippocampus and related cortical areas, non-declarative 
memory implicates other brain regions, namely the cerebellum, the striatum 
and the amygdala.  
 
Memory comprises of many processes: acquisition, which is the encoding of 
new information; consolidation, which is the process by which short-term 
memory (STM) is stabilized into a persistent long-term memory (LTM) and 
retrieval, which refers to the recall of the memory trace (Abel and Lattal, 
2001). In addition, memory can further be changed during reconsolidation, as 
newly consolidated memory may be subjected to modifications through 
reminders and interference when it is retrieved (McKenzie and Eichenbaum, 
2011). 
	  	   	   10	  
 
Classical fear conditioning in rodents is a valuable paradigm for exploring 
memory processing at the molecular level. In contextual fear conditioning 
(CFC), a mouse is placed in a conditioning chamber (context) where it 
receives a foot shock and learns to associate the context with the shock 
(memory acquisition). The mouse is then returned to its homecage, where the 
stabilization of the fear association into long-term memory is consolidated 
(memory consolidation). Retrieval occurs when the animal is placed back in 
the context in the absence of shock. Re-presentation of the context elicits 
freezing, which is a characteristic fear response in rodents (memory retrieval). 
Retrieval tests do not only reactivate the memory from acquisition (memory 
re-consolidation), but also lead to the establishment of new memories. The 
original learning can be gradually suppressed as the animal learns that the 
context no longer predicts the shock (memory extinction) (reviewed in Abel 
and Lattal, 2001).  
 
The use of pharmacological and lesion approaches in fear conditioning 
experiments has greatly contributed to our understanding of the brain regions 
and temporally distinct memory processes involved in associative learning. 
Multiple studies have demonstrated that the hippocampus is a critical 
structure underlying contextual fear memory. Electrolytic lesions of the dorsal 
hippocampus (Maren et al., 1997; Phillips and Ledoux, 1992) or 
pharmacological manipulation prior to training produce deficits in both 
acquisition and retrieval of contextual fear memory (Matus-amat et al., 2004; 
Sanders and Fanselow, 2003). Furthermore, post training hippocampal 
lesions tremendously affect contextual fear memory (Kim and Fanselow, 
1992). This means the hippocampus stores the information only for a limited 
time after conditioning. Memory consolidation involves the transfer of 
information to other brain regions such as the neocortex (Anagnostaras et al., 
1999). 
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1.2 Molecular basis of memory 
 
The identification and characterization of the molecular mechanisms 
underlying memory formation in the hippocampus have strongly benefited 
from the study of cellular models of learning, including certain forms of 
synaptic plasticity. At the cellular level, the formation of memory is 
accompanied by activity-dependent changes in synaptic transmission, a 
phenomenon that is referred to as synaptic plasticity (Neves et al., 2012). 
Various types of plasticity can be modeled in the mammalian hippocampus by 
applying electrical or chemical stimulation, and subsequent recording of 
synaptic transmission. Following neuronal stimulation, synaptic transmission 
can either be enhanced in the case of long-term potentiation (LTP) or 
repressed in the case of long-term depression (LTD) (Ho et al., 2011). 
 
There is evidence that plasticity is important for immediate learning. Notably, 
STM is mediated by transient modifications of preexisting synaptic proteins, 
i.e. (de)phosphorylation of enzymes, receptors and ion channels. These 
modifications ultimately alter the efficiency of synaptic transmission. In 
contrast, the consolidation of this plasticity into LTM is generally thought to 
depend on the activation of second messengers that initiate both gene 
transcription and the synthesis of new proteins (Kandel et al., 2014). 
 
Typically, release of the excitatory neurotransmitter glutamate from the 
presynaptic neuron and its binding to N-methyl-D-aspartate (NMDA) receptors 
and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors 
on the postsynaptic neuron cause the opening of these ionotropic glutamate 
channels. Then, membrane depolarization occurs, causing the opening of L-
type voltage sensitive calcium channels (L-VSCCs) and increased calcium 
concentrations in the postsynaptic neuron (Greer and Greenberg, 2008). 
Calcium influx through NMDA receptors and L-VSCCs is critical for activity-
dependent gene transcription, and promotes long-term plasticity. Depending 
on the route and dynamics of calcium entry (either through NMDA receptors 
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or L-VSCCs), a specific gene expression response is triggered in the nucleus 
via the activation of a range of signaling molecules such as Ca2+/Calmodulin 
dependent kinase II (CamKII), protein kinase A (PKA), protein kinase C, and 
calcineurin (Kandel, 2012). These signaling molecules are mainly composed 
of kinases and phosphatases that activate directly or indirectly various 
synaptic proteins and transcription factors (TFs). For example, CamKII 
promotes phosphorylation of AMPA receptors, thereby increasing channel 
conductance, thus enhancement of synaptic transmission, as well as 
accumulation of AMPA receptors into the synaptic membrane (Shepherd and 
Huganir, 2007). 
 
A well-characterized TF implicated in synaptic plasticity and memory in a 
variety of systems is the cyclic adenosine monophosphate (cAMP)-response 
element binding protein (CREB) (reviewed in (Carlezon et al., 2005)). For 
instance, CREB phosphorylation promotes gene transcription of cAMP 
response element (CRE)-dependent genes in combination with several 
cofactors (Lonze and Ginty, 2002). Notably, the nuclear activation of TFs 
leads to the expression of a multitude of genes. Some of them are rapidly and 
transiently induced such as the immediate early genes (IEGs). Many IEGs, 
including c-Fos and Zif/268 act as TFs themselves, thus alter neuronal 
function based on their downstream targets. As a result, a tightly coordinated 
gene expression program is induced that promotes dendritic and axonal 
growth, synapse development, and neuronal plasticity. In addition, many 
activity-dependent genes encode effector proteins that directly control various 
aspects of neuronal function, such as the brain derived neurotrophic factor 
(BDNF). Following transcription, the newly transcribed messenger RNAs 
(mRNAs) are transported to the translational machinery, in the neuronal soma 
and synapses for subesequent protein synthesis to occur. Newly synthesized 
proteins contribute to the restructuration of existing synapses and generation 
of new neuronal circuits (Sutton and Schuman, 2006). 
 
Studies examining the molecular basis of memory have found many of the 
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signaling molecules involved in synaptic plasticity to be important for memory 
acquisition and consolidation. Inducible deletion of NMDA receptor function in 
hippocampal area cornu ammonis 1 (CA1) disrupts the consolidation of 
contextual memories, but not the retrieval of these memories (Shimizu et al., 
2000). Administration of protein synthesis inhibitors after training affects LTM 
for contextual fear conditioning, indicating that the synthesis of new proteins is 
critical for contextual memories (Abel et al., 1997). For protein synthesis to 
occur, long-term contextual memory storage requires the activation of the 
cAMP/PKA/CREB pathway. In fact, a reduction in PKA hippocampal activity in 
forebrain neurons leads to selective deficits in LTM (Abel et al., 1997). During 
consolidation of contextual fear memories, two time periods of sensitivity to 
inhibitors of PKA and protein synthesis have been described: one shortly after 
conditioning, and another four hours later (Bourtchouladze et al., 1998). This 
indicates that there are waves of gene expression and protein synthesis that 
occur in the brain during memory acquisition and consolidation. CREB is 
activated after training (Bernabeu et al., 1997), and disruption of CREB alpha 
and gamma isoforms leads to impairments in the consolidation of fear 
memories (Bourtchouladze et al., 1994). Similarly, the induction of IEGs such 
as c-Fos, Arc and Bdnf observed in the hippocampus after CFC potentially 
underlies protein synthesis-dependent memory consolidation (Hall et al., 
2000; Huff et al., 2006). Importantly, gene expression and subsequent protein 
synthesis are tightly controlled processes that are regulated at multiple levels 
including transcription, translation as well as mRNA and protein transport and 
stability. 
 
 
1.3 Mechanisms of regulation of gene expression  
 
Gene transcription is a sophisticated multi-step cellular process 
mediated by the collective action of a complex enzymatic machinery 
comprising the RNA polymerase II along with sequence-specific DNA binding 
TFs and a number of co-regulators (reviewed in (Kadonaga, 2004)). TFs 
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function as coordinators between the transcriptional machinery and the 
information encoded in the DNA sequence. The recruitment of co-regulators 
(coactivators and corepressors) by TFs to proximal promoter and distal 
regulatory regions (enhancers and silencers) regulates directly and indirectly 
the activity of the basal transcriptional machinery. Some of these co-
regulators involve chromatin-remodeling complexes and histone-modifying 
enzymes, which mediate local chromatin alterations to either facilitate or 
inhibit transcription. Mechanisms that can affect the functional state of 
regulatory regions via changes in the chromatin architecture without altering 
the DNA sequence itself are referred to as epigenetic mechanisms of gene 
regulation. 
 
 
1.3.1 Epigenetic mechanisms - histone modifications  	  
In eukaryotes, chromatin is organized into nucleosomes that consist of DNA 
wrapped around octamers of histone proteins (H2A, H2B, H3, and H4 linked 
by H1). Its structure is highly dynamic and is in part, regulated by histone- 
modifying enzymes, which covalently modify the amino-terminal tails of 
histone proteins. Notably, histones can be subjected to a number of 
posttranslational histone modifications (PTMs), including acetylation, 
phosphorylation, methylation, ubiquitination and sumoylation of different 
amino-acids. These modifications are brought about by histone 
acetyltransferases/deacetylases (HATs/HDACs), histone 
methyltransferases/demethylases (HMTs/HDMs), and protein 
kinases/phosphatases, respectively. Depending on the composition of 
modifications on a given histone, the chromatin architecture, and thus, the 
accessibility of DNA to the transcriptional machinery may be affected 
(Kouzarides, 2007). 
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1.3.2 Epigenetic mechanisms - DNA methylation  
 
Another layer of epigenetic regulation includes the methylation of DNA. DNA 
methylation is a covalent DNA modification resulting from the addition of a 
methyl residue at the 5’ position of the cytosine pyrimidine ring. Together with 
DNA methylation, histone PTMs establish a dynamic epigenetic code specific 
for each gene and for each cellular state, and that determines whether the 
chromatin is in an open or condensed configuration for gene transcription or 
silencing (Kouzarides, 2007). 
 
5-methylcytosine (5mC) occurs primarily within the context of CpG 
dinucleotides in the mammalian genome, although CpH methylation (H is A, 
C, or T) has recently been identified (Guo et al., 2014; Lister et al., 2013). 
Globally, CpG dinucleotides are under-represented in the mammalian 
genome, but 60-90% of all CpGs are methylated in mammals (Deaton and 
Bird, 2011). However, certain genomic regions known as CpG islands (CGIs) 
contain a high density of CpG dinucleotides and often overlap with 
transcription start sites (TSSs) (Bird, 1986). CGI methylation in proximity of 
the TSS is associated with robust transcriptional silencing. Gene repression 
seems to be mediated by recruitment of repressive methyl-CpG binding 
domain (MBD) proteins, such as the methyl-CpG-binding protein 2 (MeCP2) 
(Klose and Bird, 2006). MBD proteins are thought to interact with HDACs and 
to establish a repressed chromatin environment. Additionally, the generation 
of 5mC within gene regulatory elements may prevent the binding of methyl-
sensitive TFs, thereby blocking transcription initiation (Liu Y, 2013). In 
contrast, methylation in the gene body positively correlates with expression 
(Bender et al., 1999). Interestingly, previous work suggests that gene body 
methylation results in suppressing intragenic promoters in mammalian cells 
(Maunakea et al., 2010) and regulating alternative splicing (Maunakea et al., 
2013), albeit the role of methylated intragenic CGIs is still unclear. Overall, 
methylation is key to multiple biological processes, including chromosome X 
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inactivation, imprinting, suppression of transposons and repetitive elements 
(Jaenisch and Bird, 2003). 
 
Methylation of cytosines is catalyzed by DNA methyltransferases (DNMTs), 
including DNMT1, DNMT3a and DNMT3b. De novo methyltransferases 
DNMT3a and DNMT3b are responsible for the establishment of novel DNA 
methylation patterns (Okano et al., 1999). Conversely, DNMT1 shows high 
affinity for hemimethylated CpGs, thereby acting as a maintenance 
methyltransferase that preserved methylation patterns throughout cell division 
(Bestor, 2000). The idea that DNA methylation patterns are conserved has 
been recently challenged because of the discovery of the ten-eleven 
translocation (TET) family of proteins (TET 1, 2 and 3) (Tahiliani et al., 2009). 
Although it is known that 5mC can be passively lost upon cell division, the 
identification of TET proteins provides a potential mechanism by which active 
DNA demethylation may occur. Specifically, TETs have the potential to 
oxidize 5mC, yielding 5-hydroxymethylcytosine (5hmC), a modified base that 
has first been identified in the mammalian genome about 40 years ago (Penn 
et al., 1972).  
 
Although not fully understood, the mechanisms of active DNA demethylation 
have been proposed to depend on a succession of biochemical reactions 
catalyzed by several specific enzymes (reviewed in (Wu and Zhang, 2014). 
5mC can be oxidized into 5hmC by TETs then deaminated by activation-
induced deaminase/apolipoprotein B mRNA/editing enzyme complex 
(AID/APOBEC) deaminases generating 5-hydroxymethyluracil (5hmU). 5hmU 
can be then excised by glycosylases and repaired by components of the base 
excision repair (BER) pathway (Guo et al., 2011a). As AID/APOBEC 
preferentially deaminates unmodified cytosines due to low activity towards 
5mC, and no detectable activity towards 5hmC (Nabel et al., 2012), an 
alternative deamination-independent pathway has been proposed. It involves 
TETs-mediated iterative oxidation of 5hmC into 5-formylcytosine (5fC) and 5-
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carboxylcytosine (5caC), followed by subsequent excision of 5caC by thymine 
DNA glycolase (TDG) (He et al., 2011; Ito et al., 2011) (Figure 1.1).  
 
1.3.3 DNA hydroxymethylation – a novel epigenetic mark? 
 
Initially thought to be a mere by-product of oxidative stress, 5hmC is now 
recognized to be a functional DNA mark that plays an important role in various 
biological processes. Although global 5mC levels are more or less similar 
across various tissue types, 5hmC content is variable. Importantly, the highest 
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Figure 1-1 Model pathway for active DNA demethylation. DNA 
methyltransferases (DNMT1, 3a/b) catalyze the methylation of cytosines and 
lead to the formation of 5-methylcytosine (5mC). 5hmC is generated by 
oxidation of 5mC by TET proteins (TET1, 2 and/or 3). TETs oxidize 5hmC to 
5-formylcytosine (5fC) and 5-carboxylcytosine (5caC), which are then excised 
by a putative decarboxylase/deformylase or thymine-DNA glycosylase (TDG) 
through base excision repair (BER) mechanisms. Alternatively, 5-hmC may 
be deaminated into 5-hmU by AID/APOBEC deaminases, and removed by 
TDG through BER mechanisms. Relevant modifications are highlighted in red. 
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prevalence of 5hmC has been found in the brain (Globisch et al., 2010; 
Kriaucionis and Heintz, 2009; Münzel et al., 2010). In addition, global 5hmC 
levels in human tissue often do not correlate with global 5mC levels (Nestor et 
al., 2011), suggesting that 5hmC has its own mechanisms of regulation. The 
relatively high levels of 5hmC in embryonic stem cells (ESCs) during early 
development (Ito et al., 2010) and in some differentiated cells, in particular 
neurons (Hahn et al., 2013), suggest that 5hmC represents a stable DNA 
modification. 
 
The functions of 5hmC are not fully understood but there is accumulating 
evidence that it might be important for transcriptional regulation. Similar to 
5mC, 5hmC is present in CpGs in both the human and in the mouse genome 
(Lister et al., 2013). Genome-wide mapping in mouse and human ESCs has 
revealed that 5hmC marks important genomic regions, such as gene bodies, 
promoters and enhancers (Ficz et al., 2011; Pastor et al., 2011; Stroud et al., 
2011; Williams et al., 2011; Wu et al., 2011; Xu et al., 2011). In the human 
frontal cortex, 5hmC is largely absent within intergenic regions, enriched 
within gene bodies, and, compared to 5mC, it is more frequently targeted to 
promoters (Jin et al., 2011). Whole genome mapping at single base resolution 
confirmed that 5hmC is localized within enhancers and the gene body in fetal 
and adult mouse brain (Lister et al., 2013). In addition, intragenic 5hmC 
appears to be enriched at exons compared to introns (Szulwach et al., 2011). 
Numerous studies have reported a robust positive correlation between 
intragenic 5hmC levels and gene expression, as well as chromatin 
accessibility (Colquitt et al., 2013; Jin et al., 2011; Lister et al., 2013; Mellen et 
al., 2012). Also, the presence of 5hmC within TSS is associated with gene 
expression levels in the case of promoters with low CpG content, but not for 
promoters with intermediate or high CpG content (Jin et al., 2011). There is 
also a significant difference in 5hmC and 5mC abundance between the sense 
and antisense strand, with 5mC enrichment on the antisense strand and 
5hmC enrichment on the sense strand (Wen et al., 2014).  
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Regulation of gene activity by 5hmC has also been suggested to involve 
methyl-CpG binding proteins (MBP). MBD3, a member of the MBD family with 
low binding affinity towards 5mC, can bind to sequences enriched in 5hmC in 
ESCs (Yildirim et al., 2011). The protein MeCP2 (another MBP) can also 
associate with 5hmC, although it binds to 5mC with much higher affinity 
(Mellen et al., 2012; Spruijt et al., 2013). Consistently, MBD1, MBD2, MBD4, 
and MeCP2 localizations also correlate with the presence of 5hmC in ESCs 
(Baubec et al., 2013). Several other 5hmC reader proteins have recently been 
identified in mouse ESCs and neurons by mass spectrometry-based 
proteomics (Spruijt et al., 2013). Oxidation of methyl residues could also play 
a role in preventing 5mC-mediated silencing. In fact, the presence of 5hmC 
strongly inhibits the binding of MBD1 and MBD2, two MBPs that recruit 
HDACs and HMTs to 5mC (Hashimoto et al., 2012). Overall, these findings 
suggest that 5hmC may be involved in global epigenetic regulation. 
 
Furthermore, profiling of the TET1 genomic distribution has revealed that 
TET1 is preferentially bound to the promoters of both repressed and actively 
transcribed genes in ESCs (Ficz et al., 2011; Pastor et al., 2011; Williams et 
al., 2011; Xu et al., 2011). As 5hmC is enriched within these regions, these 
findings corroborate the idea that TET proteins regulate 5hmC generation. 
Specifically, 5hmC and TET1 are co-enriched at promoters that carry the 
transcription repressive mark H3K27me3 or the permissive mark H3K4me3 
(bivalent promoters) (Pastor et al., 2011; Wu et al., 2011; Xu et al., 2011). 
Since 5mC is rare in such promoters, it is likely that 5hmC and TET1 are 
responsible for the regulation of these promoters, in particular in pluripotent 
and developmentally regulated genes in ESCs. More recently, accumulation 
of 5hmC and TET3 was associated with a reduction in the heterochromatin 
mark H3K9me3 and increase occupancy of the TF SP1 within the mouse 
prefrontal cortex (Li et al., 2014b). Given that both 5mC and 5hmC are 
abundant in the central nervous system (CNS) and associated with different 
aspects of transcriptional regulation, much effort has been made to 
understand the role of these DNA marks in neuronal function. 
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1.4 DNA modifications in the brain and memory 	  
1.4.1 DNA methylation and DNMTs in the brain 
 
Methylated DNA has traditionally been viewed as a stable epigenetic mark. 
However, in many cells, including post-mitotic cells like adult neurons, DNA 
methylation and demethylation occur in a dynamic manner. The first 
experimental evidence linking DNA methylation to brain activity was provided 
by Vanyushin and co-workers in 1977 who showed that active avoidance and 
food-seeking behaviors in rats affect the global level of 5mC within regions of 
the brain critical for memory formation, such as the hippocampus and the 
neocortex (Guskova et al., 1977). Many years later, the topic regained 
momentum upon the discovery that neuronal stimulation induces 
methylation/demethylation of many CpGs in different loci, such as the 
promoter of Bdnf and fibroblast growth factor-1 (Fgf1) (Ma et al., 2009). In this 
case, demethylation correlates with increased mRNA and protein expression, 
possibly due to the dissociation of repression complexes, i.e., MeCP2-Sin3 at 
the Bdnf promoter (Martinowich et al., 2003). Furthermore, DNA methylation 
mapping using methylation sensitive restriction enzymes have revealed that 
many genes undergo active DNA methylation and demethylation in vivo after 
neuronal activation in the adult mouse brain (Guo et al., 2011b). In this 
experiment, the methylation status of at least 1.4% CpGs was found to be 
changed. The methylation changes in the vicinity of putative promoters were 
anticorrelated with changes in gene expression. Consequently, DNA 
methylation in conjunction with chromatin remodeling appear to be key 
processes in the regulation of gene transcription in response to neuronal 
activity. 
 
DNA methylation and demethylation are also dynamically modulated during 
learning and memory formation in the adult rodent brain. Following CFC, DNA 
methylation increases within the promoter of the memory suppressor gene 
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PP1, but decreases at the promoter of Reelin, a memory-activating gene. In 
the hippocampus, these changes occur within 30 minutes after training but 
they are transient, as DNA methylation reaches baseline level after 24 h 
(Miller and Sweatt, 2007) . The same group has reported similar findings in 
the context of Bdnf regulation. Notably, Bdnf mRNA gradually increased in the 
area CA1 of the hippocampus in response to CFC and returned to baseline 
after 24h. CFC triggers methylation changes at multiple CGIs within the Bdnf 
locus (Lubin et al., 2008). In response to activity, methylation changes in the 
hippocampus appear to be rapid and transient. In contrast, changes in DNA 
methylation in the cortex persist and remain for several days. Shortly after 
training, the methylation profile of the gene coding for the phosphatase and 
memory suppressor calcineurin remains unaltered in the rodent prefrontal 
cortex. Within 1 day of training, however, the gene encoding calcineurin is 
subjected to a significant increase of 5mC content in its promoter region, and 
this effect is still detectable 30 days after training (Miller et al., 2010). More 
recently, a cell-specific genome-wide profiling of DNA methylation has 
pinpointed differentially methylated regions (DMRs) in neurons during memory 
consolidation and maintenance. These DMRs are preferentially located in 
intergenic and intronic regions, in particular in functional cis-regulatory 
regions. Neuron-specific genes are more likely to contain DMRs than non-
specific genes, and DMRs are enriched in genes involved in the CREB and 
PKA signaling cascades (Halder et al., 2016). These results suggest that both 
DNA methylation and demethylation are likely to contribute to gene regulation 
during memory formation.  
 
The mechanisms of DNA methylation/demethylation during memory formation 
are, at present, not fully understood. There is, however, accumulating 
evidence that DNMTs are involved in these processes. For example, the 
mRNA of de novo Dnmts, Dnmt3a/b, increases in the mouse hippocampus 
after CFC (Miller and Sweatt, 2007). Similarly, cortical Dnmt1 is subjected to 
activation in response to environmental enrichment (Rampon et al., 2000). 
Furthermore, pharmacological activation of PKC in hippocampal slices leads 
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to the upregulation of Dnmt3a mRNA specifically in the area CA1, suggesting 
that the PKC signaling cascade activates Dnmt3a expression (Levenson et 
al., 2006). In CFC, interfering with hippocampal DNMT activity using 
pharmacological inhibitors impairs LTM when delivered before or immediately 
after training (Lubin et al., 2008; Miller and Sweatt, 2007). Infusion of DNMT 
inhibitors prevents active methylation of genes known to be involved in 
memory formation, resulting in aberrant transcription levels (Miller and Sweatt, 
2007). Likewise, inducing a deficiency in DNMT1 and DNMT3a by conditional 
knockout (KO) in forebrain neurons impairs LTM in adult mice (Feng et al., 
2010). Furthermore, DNA methylation is important for synaptic plasticity, a 
cellular process that results in changes in synaptic strength and is thought to 
contribute to learning and memory. Induction of LTP in rodent hippocampus is 
blocked in the presence of DNMT inhibitors (Levenson et al., 2006). Likewise, 
hippocampal LTP is affected in DNMT1 and DNMT3a double KO mice (Feng 
et al., 2010). These findings indicate a link between DNA methylation, 
DNMTs, synaptic plasticity and memory in the adult brain.  
 
1.4.2 DNA hydroxymethylation and TETs in the brain  	  
In the adult brain, 5hmC is about 10 times higher than in other organs 
(Kriaucionis and Heintz, 2009; Li and Liu, 2011) and its abundance is brain-
region specific. It is most prevalent in the hippocampus (0.6 % of total 
cytosine bases), the cortex (0.7 %) and the cerebellum (0.3 %) (Globisch et 
al., 2010; Kriaucionis and Heintz, 2009; Münzel et al., 2010; Song et al., 
2011). 5hmC levels are also cell-type specific and vary based on 
developmental stage. In cerebellar Purkinje neurons, 0.6 % of cytosines 
display hydroxymethylation, whereas hydroxymethylation reaches only 0.2 % 
in granule cells (Kriaucionis and Heintz, 2009). In the frontal cortex, 5hmC 
content is higher in neurons compared to glia (Lister et al., 2013). Importantly, 
5hmC accumulates during brain development in mice (Lister et al., 2013; 
Song et al., 2011), in particular in developmentally activated genes compared 
to repressed or silent genes (Szulwach et al., 2011). Similarly, genes 
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associated with neuronal differentiation acquire 5hmC in the course of 
differentiation in their bodies. This increase in hydroxymethylation correlates 
with gene activation (Colquitt et al., 2013; Hahn et al., 2013). Likewise, 
neuronal activity induces changes in global 5hmC levels in the CA1 region of 
the hippocampus (Kaas et al., 2013). Overall, 5hmC is subjected to dynamic 
fluctuations and associated with transcriptional regulation in the brain. 
 
5hmC synthesis is performed by the 5mC dioxygenases, TET1, 2 and 3, all of 
which require Fe2+ as cofactor and alpha-ketoglutarate as cosubstrate 
(Tahiliani et al., 2009) (Figure 1.2). Although all TET proteins share a 
conserved C-terminal catalytic domain that includes a double-stranded β-helix 
fold, they differ in terms of their N-terminal DNA-binding CXXC domain. Both 
TET1 and TET3 harbour a CXXC domain that binds to CpG dinucleotides. 
TET2, however, lost its N-terminal CXXC domain, which is now encoded by a 
neighboring gene termed Idax/Cxx4 (Ko et al., 2013). 
 
 
 
Figure 1-2 Pathway for generation of 5hmC by TET enzymes. TET uses 
oxygen (O2) as a substrate to catalyze oxidative decarboxylation of alpha-
ketoglutarate (α-KG), thereby generating a reactive high-valent enzyme-
bound Fe(IV)-oxo intermediate (not illustrated) that converts 5-
methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC). CO2 and 
succinate are by-products of the reaction. 
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TET1, 2 and 3 are all expressed in the nervous system. TET1 is enriched in 
undifferentiated ESCs and is low in the adult brain, whereas TET2 and 3 are 
abundant in the adult brain (Szwagierczak et al., 2010). Although all TETs 
have the same enzymatic activity, they are thought to contribute differently to 
biological processes due to their different spatial and temporal distribution.  
 
1.4.2.1 TET1 
 
Even though it is only weakly expressed in the adult brain, TET1 is the most 
thoroughly characterized TET protein to date. TET1 whole body deficiency in 
mice does not affect brain morphology and development (Rudenko et al., 
2013; Zhang et al., 2013b). However, brain processes like neurogenesis and 
hippocampal long-term depression are altered in these mice (Zhang et al., 
2013b). Many studies have reported memory impairment upon Tet1 KO in 
mice, but contrasting results have been found as to which memory type and 
process are affected. Using Morris water maze (MWM), Zhang et al. observed 
deficits in spatial STM but normal LTM (Zhang et al., 2013b). In contrast, 
Rudenko and colleagues reported normal memory acquisition but deficits in 
memory extinction in MWM and fear conditioning (Rudenko et al., 2013). 
Another group found unaltered memory acquisition in Tet1 KO mice upon fear 
conditioning, albeit memory consolidation and LTM was enhanced (Kumar et 
al., 2015). Tet1 overexpression in the hippocampus impairs LTM in fear 
conditioning, whereas STM is not affected (Kaas et al., 2013). This effect is 
independent of TET1 catalytic activity as inactivation of TET1 catalytic domain 
leads to similar observations. The contrasting results obtained using the Tet1 
KO model might be due to the fact that all three Tet genes are expressed in 
the brain and may exhibit some functional redundancy. 
 
At the molecular level, Tet1 mRNA is downregulated in response to CFC in 
dorsal CA1 hippocampus, suggesting that its expression is regulated in an 
activity-dependent manner (Kaas et al., 2013). Tet1 overexpression in the 
hippocampus leads to reduced methylation at the promoters of Bdnf and Fgf1, 
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two genes that exhibit activity-induced active DNA demethylation in the 
dentate gyrus. This effect is accompanied by an upregulation in transcript 
levels of both Bdnf and Fgf1 (Guo et al., 2011c). Conversely, Tet1 and 
Apobec1 knockdown in the dentate gyrus of the hippocampus prevents 
activity-induced active DNA demethylation of Bdnf and Fgf1 promoters. This 
suggests that TET1 and APOBEC1 work synergistically in active DNA 
demethylation in the mouse brain. Furthermore, Tet1 overexpression leads to 
a significant upregulation of several activity-dependent neuronal genes, 
including c-Fos, Arc, Egr1, as well as genes involved in the DNA 
demethylation pathway such as Tdg and Apobec1. Conversely, c-Fos, Arc, 
Egr2 and Npas4 expression levels are decreased in the hippocampus of Tet1 
KO mice (Rudenko et al., 2013). Further analysis revealed hypermethylation 
of the Npas4 promoter-exon 1 junction region, providing a potential 
mechanism for the observed downregulation of Npas4 in Tet1 KO mice.  
 
1.4.2.2 TET2 
 
Unlike TET1, the role of TET2 in the adult brain has not been extensively 
studied. TET2 has been proposed to play a role in DNA demethylation of 
development-dependent genomic regions during brain development. Indeed, 
whole-genome bisulfite sequencing in the frontal cortex of Tet2 KO mice 
identified 4-fold more hypermethylated CpGs compared to wild-type in the 
course of brain development (Lister et al., 2013). Furthermore, TET2 was 
found to play a role in synaptic transmission, as shRNA-mediated knockdown 
of Tet2 in hippocampal neurons affects basal levels of synaptic transmission 
(Yu et al., 2015). 
 
1.4.2.3 TET3 	  
Among the TET family, Tet3 is the most expressed gene in neurons (Colquitt 
et al., 2013). Tet3 exists in three major isoforms produced through alternative 
splicing i.e. an oocyte-specific isoform, an isoform containing a CXXC domain, 
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and an isoform lacking the CXXC domain (Jin et al., 2016). Specifically, the 
isoform lacking the CXXC domain is enriched in neuronal tissue (Liu, 2013; 
Perera 2015), and was found to interact with the RE1-Silencing Transcription 
factor (REST) and various HMTs such as NSD3, NSD2 and SETD2 (Perera et 
al., 2015). In line with the observation that TET3 is involved in gene 
transcriptional regulation of neuronal genes, TET3 was proposed to be a 
transcriptional activator of early eye and neural development in Xenopus 
laevis (Xu et al., 2012). 
 
In summary, epigenetic mechanisms, including DNA (hydroxy)methylation 
and histone modifications, are implicated in controlling gene expression at the 
transcriptional level in the brain. The complex network of gene expression and 
epigenetic regulation is complemented by other regulatory mechanisms. In 
particular small (19 to 22 nucleotides) endogenous non-coding RNAs termed 
microRNAs (miRNAs). MiRNAs are potent post-transcriptional regulators that 
are implicated in the control of numerous biological processes, including 
memory formation and maintenance (Woldemichael and Mansuy, 2016).	   
 
 
1.5 miRNAs and their regulatory role in the brain 
 
MiRNAs are particularly relevant for the formation of LTM due to their 
localized and inducible expression level, rapid turnover and combinatorial 
mode of action. They are therefore ideal candidates for orchestrating and fine-
tuning gene expression related to synaptic plasticity and memory formation. 
 
1.5.1 Role of miRNAs in synaptic plasticity and learning and 
memory 
 
Many miRNAs are enriched in the CNS, mainly in a region-specific manner 
(Juhila et al., 2011). Interestingly, some miRNAs are specifically enriched in 
dendrites and synaptosomes, such as miR-134. This miRNA operates locally 
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to control dendritic spine morphology and development by negatively 
regulating the expression of the synaptic protein LIMK1 (Schratt et al., 2006). 
Furthermore, miR-134 overexpression in the hippocampus impairs synaptic 
plasticity and memory formation via translational repression of Creb and Bdnf 
(Gao et al., 2010). Several other studies have reported the importance of 
miRNAs in regulating gene expression in the context of learning and memory 
(reviewed in Saab and Mansuy, 2014). In this regard, the best-characterized 
neuronal miRNAs are miR-132 and miR-212. Deletion of the miR-132/212 
locus in excitatory neurons of the hippocampus leads to significant 
impairments in memory retrieval and spatial memory (Hansen et al., 2016), 
whereas overexpression of miR-132 enhances cognitive functions (Hansen et 
al., 2013). Thus, manipulation of specific brain miRNA expression levels 
affects higher-order brain function in vivo. 
 
Activity-dependent regulation of gene expression is crucial for synaptic 
plasticity and memory formation, and this is also true for many miRNAs. In 
cultured neurons, miR-132 expression is consistently increased in response to 
neuronal activity (Klein et al., 2007; Vo et al., 2005; Wayman et al., 2008). 
Likewise, miR-132 is upregulated in specific brain regions in a variety of 
learning paradigms, including CFC (Nudelman et al., 2010). CFC induces 
widespread changes in the hippocampal miRNA profile mostly in an NMDA-
dependent manner, suggesting that they are likely related to learning and 
memory formation (Kye et al., 2011). In line with this finding, numerous 
studies have shown that the expression of miRNAs is dynamically modulated 
during neuronal activity and memory formation (reviewed in Sim et al., 2014). 
In the hippocampus, a fraction of the activity-regulated miRNAs follow a 
biphasic pattern of expression, i.e., a rapid induction is followed by a decline, 
whereas other miRNAs undergo no induction but decrease in expression at 
later time points (Eacker et al., 2011). This is consistent with the observation 
that miRNAs exhibit a high turnover rate in neurons, and this general property 
of neuronal miRNAs is dependent on activity (Krol et al., 2010a). Intriguingly, 
certain miRNAs, such as miR-29b, contain specific sequence elements that 
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are required for their rapid decay (Zhang et al., 2011). In conclusion, the 
literature precedent suggests that neuronal-activity dependent regulation of 
miRNA may fine-tune gene expression patterns that are required for synaptic 
plasticity and memory formation. 
 
1.5.2 Biogenesis of miRNAs 
 
Mature miRNAs originate from their primary miRNA transcript (pri-miRNA) that 
is typically transcribed by RNA polymerase II and occasionally by RNA pol III 
(Borchert et al., 2006; Cai et al., 2004; Lee et al., 2004). Pri-miRNA is 
composed of a hairpin structure containing a terminal loop, a double-stranded 
stem and flanking single stranded sequences. The pri-miRNA transcript is 
cleaved within the nucleus by the microprocessor complex that is composed 
of DROSHA, a nuclear RNAse III endonuclease, and DiGeorge syndrome 
critical region gene 8 (DGCR8), a double-stranded RNA binding protein 
(RBP). Briefly, DGCR8 mediates the recognition of the double stranded stem 
of the pri-miRNA hairpin, and guides Drosha to the cleavage site. The 
cleavage site is located at approximately 11 bp away from the basal junction 
of the stem, and cleavage by DROSHA at this site generates the precursor 
miRNA (pre-miRNA). Pre-miRNAs are then exported to the cytoplasm via the 
Exportin-5 pathway (Lund et al., 2004). In the cytoplasm, further processing of 
pre-miRNAs is carried out by another RNAse III enzyme named DICER. 
DICER, in combination with its partner TAR RNA binding-protein (TRBP), 
cleaves the pre-miRNAs at their terminal loops, thus releasing a double 
stranded RNA of 20-24 nt length. One of these two strands i.e. the guide 
strand is incorporated into the miRNA-induced silencing complex (miRISC) 
and becomes functional. The strand selection depends on the thermodynamic 
properties of each strand. In fact, the strand with the weakest 5’ end pairing is 
preferentially loaded into the miRISC, while the other strand (passenger 
strand) is released and degraded (Yates et al., 2013). The core of the miRISC 
is mainly composed of argonaute proteins and their partners GW182 proteins, 
which play a key role in the assembly and function of miRISCs. The retained 
miRNA within the miRISC guides the complex to mRNAs. MiRNAs usually 
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binds to the 3’UTR of target mRNAs through imperfect base-pairing via the 
seed sequence. This mediates inhibition of protein synthesis by repression of 
translation. Translational inhibition occurs at both initiation by interfering with 
ribosome recruitment (Humphreys et al., 2010; Mathonnet et al., 2007) and 
post-initiation steps (Maroney et al., 2006; Petersen et al., 2006) but the 
molecular mechanisms involved are still unclear. The miRISC also promotes 
deadenylation/decapping via recruitment of deadenylase complexes, which 
facilitate degradation of target mRNAs by exonucleases (Fabian and 
Sonenberg, 2012) (Figure 1.3). Most miRNAs are produced through the 
canonical pathway of miRNA biogenesis, involving both transcriptional and 
post-transcriptional processes. Importantly, the biogenesis of miRNAs is 
tightly regulated, mainly by RBPs. RBPs are implicated in most steps of 
miRNA biogenesis i.e. from the production of the pri-miRNA transcript to the 
miRISC formation (extensively reviewed in Ha and Kim, 2014).  
 
MiRNA loci are located within various genomic contexts with the majority of 
canonical miRNAs being encoded by introns of coding and non-coding 
transcripts. Notably, miRNAs are under the control of proximal and distal 
regulatory regions and their promoters share similar Pol II regulatory elements 
as those of protein-coding genes, including CGI, TSS, TF binding sites, 
histone marks, etc (Corcoran et al., 2009; Monteys et al., 2010). Similarly to 
protein-coding genes, miRNA loci can therefore serve as target for the 
epigenetic machinery. Conversely, a subset of miRNAs defined as epi-
miRNAs can directly target effectors of the epigenetic machinery, such as 
HDACs and DNMTs. 
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Figure 1-3 Canonical miRNA biogenesis pathway. MiRNAs are transcribed into 
primary miRNA and processed by the microprocessor, a complex composed of the 
RNaseIII Drosha, and its binding partner DGCR8. The product of this cleavage, the 
precursor miRNA, is then exported to the cytoplasm and further cropped by Dicer. 
The miRNA duplex, composed of the guide miRNA and the passenger miRNA, is 
loaded onto an AGO protein to form the RISC. After binding to the target mRNA, 
RISC serves as a scaffold for GW182 and a deadenylase complex that facilitates 
mRNA degradation. 
	  	   	   31	  
1.6 Interplay between miRNAs and the epigenetic 
machinery: epi-miRNAs 
 
The first characterized epi-miRNAs are the members of the miR-29 family. 
The miR-29 family includes miR-29a, miR-29b-1, miR-29b-2 and miR-29c. 
MiR-29a and miR-29b-1 form a cluster, and are co-transcribed as a 
polycistronic primary transcript. Likewise, miR-29b-2 and miR-29c are 
transcribed together. Mature miR-29s share an identical seed sequence at 
nucleotide positions 2-7, implying that their target genes highly overlap. 
Importantly, the miR-29 family has been reported to indirectly influence the 
DNA methylation machinery by controlling TFs that regulate DNMT1 gene 
transcription (Garzon et al., 2009) but also by directly targeting de novo 
DNMTs. A study by Fabbri and colleagues revealed that changes in the 
expression level of miR-29s lead to aberrant patterns of methylation in lung 
cancer cell lines. In these cells, miR-29s were found to target both DNMT3a 
and b via direct binding to their 3’UTRs (Fabbri et al., 2007). Interestingly, 
several in silico methods (TargetScan, MiRanda) used for prediction of 
miRNA-target interactions reported the presence of multiple well-conserved 
miR29-binding sites within the 3’UTR of all Tet transcripts (Figure 1.4).  
 
 
-––- 
 
Figure 1-4 miR-29 family has multiple well-conserved and predicted 
binding sites within Tet3 3’UTR. Examples of complementary sites for miR-
29s in the 3’UTR region of human and mouse Tet3 according to TargetScan 
prediction. Adapted from targetscan.org 
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This led us to postulate that miR-29s may regulate the expression of both 
DNA methyltransferases and demethylases. This observation suggests that 
the expression of miR-29s in the brain likely contribute to the regulation of 
effectors of the DNA epigenetic machinery, including TET proteins in the 
context of learning and memory. In the present thesis, we therefore aimed to 
elucidate the interplay between miR-29s and the TET proteins in the brain 
upon formation of memory. 
 
1.7 Overview 
 
MiRNAs and epigenetic mechanisms play a central role in neuronal 
morphogenesis, synaptic plasticity and also in higher-order brain function 
such as learning and memory (Chapter 1). It is therefore unsurprising that 
disruption of miRNA and epigenetics pathways has been implicated in a broad 
range of neurodevelopmental, neurodegenerative and psychiatric disorders. In 
Chapter 2, we discuss the contribution of dysregulated epigenetic 
mechanisms to the etiology and pathophysiology of neurodevelopmental and 
neurodegenerative disorders, using Rett syndrome and Alzheimer’s disease 
as examples. Further, it describes the involvement of epigenetic mechanisms 
in the development of depression and their role in mediating the effect of anti-
depressants, illustrating the role of the epigenome in psychiatric disorders. It 
ends with a brief description of how epigenetic modifications induced by early 
life trauma can influence brain functions in the adult, and how these effects 
are thought to be transmitted through epigenetic mechanisms across 
generations.  
In the brain, active DNA methylation and demethylation are dynamic 
processes that are required for learning and memory formation. DNMTs are 
induced in the brain after learning, but the mode of regulation of TETs remain 
mostly unexplored. In Chapter 3, we characterize the activity-dependent 
expression of TET family members both in vivo and in vitro, and further 
investigate the possibility that they are under the control of miR-29-mediated 
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regulatory mechanisms. The findings of the thesis are summarized and further 
discussed in Chapter 4. In this chapter, we also conclude by proposing a 
model by which TETs are regulated in the brain upon neuronal activity. 
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2.1 Abstract 
 
Emerging evidence suggests that epigenetic mechanisms are necessary for 
the development and maintenance of neuronal networks in the brain, and for 
higher-order brain processes like cognitive functions and behavior. Defects in 
epigenetic mechanisms are now known to alter disease susceptibility, 
contribute to the etiology or pathophysiology of some disorders, and also 
determine the response to therapies. A large body of literature implicates 
epigenetic dysfunctions in neurodevelopmental disorders such as Rett 
syndrome (RS), Fragile X and Rubinstein-Taybi syndrome, and in 
neurodegenerative and psychiatric conditions like Alzheimer disease (AD), 
frontotemporal lobar degeneration (FTLD), depression and schizophrenia. 
Epigenetic mechanisms also contribute to transgenerational effects of the 
environment on brain and body functions, and to the resulting inheritance of 
pathologies across families.  
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2.2 Introduction 
 
The brain is a complex organ that is highly plastic during development and 
that keeps some plasticity and responsiveness throughout life. In mammals, 
this plasticity is particularly high during pre-natal, post-natal and pubertal 
periods. It is characterized by the formation and maintenance of synapses, 
the formation of new neurons, their integration into existing neuronal 
networks, and the re-organization of neuronal networks. This plasticity is 
essential for brain processes such as learning and memory formation, and 
requires active changes in gene expression. Several brain disorders result 
from dysfunctional or impaired regulation of the molecular processes 
governing brain plasticity, underscoring their potential role in the pathogenesis 
of brain disorders.  
 
Gene expression in the brain is modulated in a cell, region, and context-
specific manner by epigenetic mechanisms. These mechanisms operate at 
the transcriptional and post-transcriptional level in response to activity. They 
can implicate several processes involving DNA methylation (reviewed in 
(Tognini et al., 2015)) histone modifications (reviewed in (Rudenko and Tsai, 
2014)), and non-coding RNAs (ncRNAs) such as microRNAs (miRNAs) 
(reviewed in (Follert et al., 2014; Wang et al., 2012)). Additional processes 
like prion-like seeding (reviewed in (March et al., 2016)), nucleosome 
positioning (Brown et al., 2015), histone turnover (Maze et al., 2015), 
competitive endogenous RNAs (reviewed in (Thomson and Dinger, 2016)) 
also constitute active non-genetic regulation in the brain. This chapter 
describes the contribution of DNA methylation, histone modifications, and 
miRNAs to brain disorders using a neurodevelopmental, neurodegenerative 
and psychiatric disorders as examples. It also indicates how epigenetic 
processes contribute to the effects of early post-natal life adversity on brain 
functions and their transmission to subsequent generations.  
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2.2.1 Epigenetic mechanisms important for the brain 	  
2.2.1.1 DNA methylation 	  
DNA methylation most commonly occurs at cytosine-guanine dinucleotides 
(CpG), although CpH methylation (H is A, C or T) is also present in the human 
and mouse brain postnatally (Guo et al., 2014; Lister et al., 2013). CpG 
methylation has traditionally been viewed as a fairly stable epigenetic mark 
mostly responsible for gene silencing. Silencing takes place by direct 
inhibition of the binding of transcription factors, or by recruitment of methyl-
CpG binding proteins (MBPs) and associated repressive chromatin-
remodeling components (Bird, 2002; Klose and Bird, 2006). However since 
CpG methylation is also present at the promoter and coding region of actively 
transcribed genes, it can also be associated with transcriptional activity 
(Bahar Halpern et al., 2014; Jones et al., 1998). Recent evidence has shown 
that in many cells including post-mitotic cells like adult neurons, DNA 
methylation is dynamically regulated and CpGs can be actively methylated 
and demethylated. DNA demethylation involves a succession of biochemical 
steps implicating several enzymes. During this process, 5-methylcytosine 
(5mC) is successively oxidized into 5-hydroxymethylcytosine (5hmC), 5-
formylcytosine (5fC) and 5-carboxylcytosine (5cAC) by ten-eleven 
translocation (TET) proteins. 5fC and 5cAC can ultimately be removed and 
repaired by terminal deoxytidyl transferases generating an unmodified 
cytosine (Kohli and Zhang, 2013). In contrast to 5fC and 5cAC, 5hmC is 
enriched in the adult brain, especially in the hippocampus, cortex and 
cerebellum (Globisch et al., 2010; Münzel et al., 2010; Song et al., 2011). The 
high abundance and stability of 5hmC in the brain (Bachman et al., 2014), 
suggest that this cytosine modification may not only be a transient by-product 
of 5mC metabolism but may also serve as an independent epigenetic mark 
thought to play an important role in brain processes. As both DNA methylation 
and hydroxymethylation patterns are modulated during development and upon 
neuronal activity and memory processes in different brain regions (Lister and 
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Mukamel, 2015), alterations in their profile may be relevant for the 
development of brain disorders. 
 
2.2.1.2  Histone modifications 	  
Covalent posttranslational modifications (PTMs) of histone proteins are other 
important epigenetic marks that primarily involve acetylation, methylation, 
phosphorylation, ubiquitination, and SUMOylation (reviewed in (Bannister and 
Kouzarides, 2011)). These modifications control the accessibility of the 
chromatin to the transcriptional machinery, in a sequence and activity-
dependent manner (Bannister and Kouzarides, 2011). Generally, acetylation 
and phosphorylation, occurring respectively on lysine and serine, threonine or 
tyrosine (residues, are associated with transcriptional activation (Li et al., 
2007). Histone methylation on lysine is associated with both actively 
transcribed and silenced genes (Klose and Zhang, 2007; Peters and 
Schübeler, 2005). Similarly, histone ubiquitination is associated with both 
transcriptional silencing and activation depending on whether it occurs on 
H2A or H2B respectively (reviewed in (Cao and Yan, 2012)). Finally, histone 
SUMOylation, which requires addition of small-ubiquitin like modifier (SUMO) 
to histones, negatively regulates gene transcription in the brain, often in 
association with other epigenetic regulators (Cheng et al., 2014a; Stielow et 
al., 2014). Importantly, histone PTMs are integral to the regulation of 
important physiological brain processes. For instance, synaptic mechanisms 
underlying hippocampal memory formation require dynamic changes in 
histone acetylation and methylation (Gräff et al., 2012a; Kerimoglu et al., 
2013; Mahgoub and Monteggia, 2014). Similarly, histone acetylation is 
essential to the resistance of neurons against ischemic or oxidative insult 
(Ryu et al., 2003; Yildirim et al., 2014). Enzymes important for regulation of 
major histone PTMs, such as histone acetyl transferases (HATs), histone 
deacetylases (HDACs), and histone methyltransferases (HMTs) are abundant 
in the brain. Owing to this and the important roles for histone PTMs in brain 
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processes, their critical involvement in brain disorders has become an 
important topic of current investigations (Volmar and Wahlestedt, 2015). 
 
2.2.1.3 MicroRNAs  	  
Epigenetic regulation of gene expression can also be achieved by ncRNAs 
like miRNAs. MiRNAs are 20-22 nucleotide long RNAs that act by 
translational repression or degradation of mRNA targets (reviewed in (Ha and 
Kim, 2014)). MiRNA biogenesis involves a succession of steps in the cell 
regulated by the RNAses Drosha and its partner DiGeorge syndrome critical 
region 8  (DGCR8) in the nucleus, followed by further processing by another 
RNAse Dicer and its partner TAR RNA binding protein (TRBP) in the 
cytoplasm. Once formed, miRNAs associate with Argonaute proteins in the 
cytoplasm to form an RNA-induced silencing complex (RISC). A number of 
RNA-binding proteins can additionally modulate the efficiency of the 
microprocessor, Dicer or RISC (reviewed in (Ha and Kim, 2014)). Many 
miRNAs and components of miRNA biogenesis machinery are abundantly 
expressed in the brain, mostly in a region-specific manner. They have been 
linked to important brain processes like neurogenesis (reviewed in 
(Wakabayashi et al., 2014)), neuronal activity (reviewed in (Elramah et al., 
2014)), and memory formation (reviewed in (Saab and Mansuy, 2014)). 
Animal models with experimental manipulation of global miRNA biogenesis or 
functional inhibition/overexpression of specific miRNAs can lead to 
pathological phenotypes, highlighting their important contribution to brain 
disorders (reviewed in (Wang et al., 2012)). Importantly, some proteins like 
the methyl-DNA binding protein MeCP2 or the protein phosphatase PP1 can 
regulate multiple epigenetic pathways in a tissue- and context-specific manner 
(Gräff and Mansuy, 2008; Jenuwein and Allis, 2001; Turner, 2002). When the 
expression of such epigenetic regulators is perturbed, for instance 
experimentally and in disease states, many core brain processes are affected, 
underscoring their likely implication in brain disorders (Gräff and Mansuy, 
2008; Jenuwein and Allis, 2001; Turner, 2002).  
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2.2.2 Epigenetic dysregulation in neurodevelopmental 
disorders - The example of Rett syndrome 
 
Neurodevelopmental disorders are characterized by impaired functions of the 
central nervous system (CNS) that appear early in development and often 
persist into adulthood. The impairments may manifest early in life like in case 
of fetal alcohol syndrome, or later. Several genetically-determined 
neurodevelopmental disorders have been documented to also involve 
epigenetic dysregulation that alter physiological functions (reviewed in (Millan, 
2013)). This chapter focuses on Rett syndrome (RS), a disorder associated 
with aberrant DNA methylation, histone PTMs and miRNAs (reviewed in 
(Kubota et al., 2013; Lyst and Bird, 2015)). 
 
RS is a relatively common (worldwide prevalence of 1:10’000) and 
progressive neurological disorder characterized by an arrest of CNS 
development and intellectual disability. It is generally caused by loss-of-
function mutations in the X-linked methyl-CpG-binding protein 2 (MeCP2) 
gene (Amir et al., 1999), which is lethal when hemizygous in males, and 
therefore affects exclusively females. MeCP2 is normally abundant in the 
brain, in particular in neurons where its level is comparable to that of histone 
octamers (Skene et al., 2010). It is a member of the methyl binding protein 
(MBP) family that binds methylated CpGs with high affinity to regulate gene 
transcription in a bidirectional fashion. MeCP2 has three domains, a methyl 
binding domain (MBD), a transcriptional repressor domain (TRD), and a WW 
domain (Weaving et al., 2005). MeCP2 not only binds to methylated CpG, it 
also recognizes methylated CpH (H=A, C or T) (Guo et al., 2014), and 
hydroxymethylated CpGs (Mellen et al., 2012), suggesting that it substantially 
decorates DNA and when deficient, like in MeCP2 mutant mice, may strongly 
perturb the profile of 5mC and 5hmC (Szulwach et al., 2011). This can have 
significant functional consequences since MeCP2 binding to 5mC contributes 
to transcriptional regulation through the recruitment of HDACs and other 
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transcriptional co-repressor complexes, such as Sin3a/HDACI, resulting in 
chromatin compaction and gene silencing (Weaving et al., 2005). In addition 
to acting as a transcriptional repression, MeCP2 is thought to also function as 
transcriptional activator. This may be by interacting with transcription factors 
like CREB1 at the promoter of target genes (Chahrour et al., 2008), and/or 
through binding to 5hmC, an epigenetic mark enriched in the body of highly 
expressed genes. Hence, MeCP2 appears to be an adapter molecule, acting 
as a promiscuous DNA binding protein that helps recruits transcriptional 
regulators. 
 
In humans, RS can be caused by loss-of-function mutations in either MeCP2 
MBD or TRD (Amir et al., 1999). Mis-sense mutations are generally milder 
while non-sense mutations cause more severe symptoms. Similarly, MBD 
mutations generally lead to a more severe phenotype (Weaving et al., 2005). 
In mice, neuron-specific MeCP2 deletion has been shown to recapitulate RS 
symptoms. MeCP2-deficient mice have reduced brain weight and abnormal 
brain circuitry (Chen et al., 2001), an overall decrease in exploratory activity 
(Chen et al., 2001; Guy et al., 2001), cognitive deficits and impaired synaptic 
plasticity (Gemelli et al., 2006). MeCP2 ablation in forebrain GABAergic 
neurons also impairs sensory information processing (Goffin et al., 2014), a 
symptom present in RS patients. Some of the cognitive deficits induced by 
MeCP2 deficiency could be reversed by overexpression of wild-type human 
MeCP2 in young mutant mice (Collins et al., 2004), confirming that they 
resulted from a lack of MeCP2. However at the same time, MeCP2 
overexpression induces seizures, suggesting that excess in MeCP2 is also 
deleterious for brain functions, and may lead to neurological functions related 
to RS.  
 
Since MeCP2 functions as a transcriptional regulator, dysregulation of its 
target genes likely contribute to RS symptoms. Global transcriptome analyses 
in human RS brain and MeCP2-deficient mice have shown dysregulation of a 
multitude of genes.  Genes with long sequences, in particular, appear to be 
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prime targets of MeCP2-mediated transcriptional repression in the mouse 
brain (Gabel et al., 2015; Sugino et al., 2014). Many of these long genes 
encode proteins implicated in neuronal physiology, axon guidance and 
synapse formation such as the calcium/calmodulin-dependent kinase 
Camk2d, and the voltage-gated potassium channel Kcnh7, and may explain 
neuronal dysfunctions in RS (Gabel et al., 2015). Importantly, these genes 
contain a high density of methylated CpA required for length-dependent gene 
repression by MeCP2. 
 
An important target is the brain-derived neurotrophic factor (Bdnf) gene, which 
expression is reduced in MeCP2-null mice. Overexpression of BDNF in 
MeCP2-null mice ameliorates the phenotype, it reduces neuronal atrophy and 
improves survival (Chang et al., 2006). In addition, delivery of exogenous 
BDNF restores synaptic dysfunctions in MeCP2-null mice (Kline et al., 2010), 
suggesting that changes in gene expression in MeCP2 mutants have an 
impact on RS phenotype. Further to Bdnf, many other genes including myelin-
associated proteins and dopamine decarboxylase, have been identified as 
direct binding targets of MeCP2 in the mouse brain (Gabel et al., 2015; 
Urdinguio et al., 2008). MeCP2 also interacts with other proteins, including 
chromatin-modifying factors (Jones et al., 1998; Nan et al., 1998), epigenetic 
regulators such DNMT1 and TET1 (Cartron et al., 2013), and transcriptional 
modulators, such as coREST, suv39H1, cSK1, etc. (Lyst and Bird, 2015), and 
therefore can influence the epigenetic profile (DNA methylation) of target 
genes. It can also influence histone PTMs, in particular histone acetylation 
and methylation (see Figure 2.1).  
 
For Bdnf, these changes are mediated by the formation of a complex between 
MeCP2 and HDAC1, reducing H3 and H4 acetylation. This is paralleled by 
increased H3K9 dimethylation, which inhibits gene transcription, but 
decreased H3K4 dimethylation, which promotes gene transcription 
(Kouzarides, 2007). 
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Figure 2-1 Roles of MeCP2 as regulator of the epigenetic code. (a) 
MeCP2 translation is regulated by miRNAs. For example, miR-132 targets 
MeCP2 mRNA in neurons, which ultimately leads to increased Bdnf transcript 
levels. (b). MeCP2 regulates gene expression post-transcriptionally by 
modulating miRNA processing via interfering with the assembly of Drosha and 
DGCR8 complex. MeCP2 can selectively modulate the biogenesis of certain 
miRNAs, in particular miR-15a. This miRNA is implicated in neuronal 
maturation by controlling Bdnf expression levels. (c) MeCP2 functions as a 
transcriptional repressor by either recruiting transcriptional co-repressor 
complexes (e.g NCoR) and/or histone deacetylases (e.g HDAC1). 
Recruitment of HDAC1 results in reduced acetylation of H3 and H4 at Bdnf 
promoter as well as increased H3K9 dimethylation and decreased H3K4 
dimethylation. This leads to chromatin condensation, thus limited access to 
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the transcriptional machinery and mediates decreased Bdnf transcription. (d) 
MeCP2 also functions as a transcriptional activator by interacting with 
transcription factors such as CREB1 at the promoter of target genes. 
Recruitment of CREB1 results in chromatin remodeling permissible for 
transcription. In addition, phosphorylation of MeCP2 can result in the inability 
of MeCP2 to bind to its methylated binding sites and interferes with the 
recruitment of NCoR. Further, MeCP2 SUMOylation increases CREB DNA 
binding, thus enhancing Bdnf mRNA expression. (e) MeCP2 binds to both 
methylated and hydroxymethylated cytosines, and interacts with epigenetic 
regulators such as DNMT1 and TET1. MeCP2 could therefore influence the 
epigenetic profile (DNA methylation) of target genes such as Bdnf. 
 
This indicates complex and possibly self-compensatory mechanisms between 
transcriptional programs regulated by MeCP2 as a result of its dual role in 
DNA methylation and histone modifications (Kubota et al., 2013; Shahbazian 
et al., 2002). Notably, the activity and expression of MeCP2 itself is under the 
control of posttranslational modifications. Activity-dependent phosphorylation 
of MeCP2 at threonine 308 regulates its transcriptional repressor activity by 
modulating its interaction with the nuclear receptor co-repressor complex 
(NCoR) (Ebert et al., 2013). Similarly, MeCP2 SUMOylation is an important 
regulator of transcriptional repressor activity which can rescue the behavioral 
deficits in mutant-MeCP2 model of RS (Tai et al., 2016).  
 
Further to DNA methylation and histone modifications, miRNAs are also 
involved in RS symptoms (Lyst and Bird, 2015). Some miRNAs mediate their 
effect by regulating MeCP2 expression, for instance, MeCP2 is a putative 
target of miR-132, a CREB-dependent miRNA (Klein et al., 2007). Similarly, 
miR-22 promotes the differentiation of smooth muscle cells from stem cells by 
controlling post-transcriptional expression of MeCP2 (Zhao et al., 2015). 
MiRNAs may also be down-stream effectors of MeCP2 dysfunction in RS 
since MeCP2 was recently shown to regulate the microprocessor-mediated 
biogenesis of miRNAs by interfering with Drosha-DGCR8 binding (Cheng et 
al., 2014b). Through this interaction and possibly others, MeCP2 can 
selectively modulate the microprocessor-mediated biogenesis of miR-137 
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(Smrt et al., 2010), miR-199a (Tsujimura et al., 2015), and miR-15a (Gao et 
al., 2015). These miRNAs regulate important molecular pathways, such as 
neuronal maturation (Smrt et al., 2010), mammalian targets of rapamycin 
signaling (Tsujimura et al., 2015), and BDNF expression (Gao et al., 2015) 
respectively, and hence likely contribute to RS etiology and/or phenotype.  
 
In conclusion, a large body of evidence supports the involvement of epigenetic 
mechanisms in RS, primarily related to a multi-dimensional and intricate role 
of MeCP2 as regulator of the epigenetic code. Future studies should examine 
the potential crosstalk of different epigenetic mechanisms regulated by 
MeCP2 to identify safe and potent therapeutic targets for RS.  
 
2.2.3 Epigenetic dysregulation in neurodegenerative 
disorders - The example of Alzheimer’s disease 
 
Neurodegenerative diseases are pathological conditions characterized by a 
gradual loss of cells in the nervous system. In the CNS, such loss usually has 
devastating consequences on cognition and locomotion. A hallmark feature of 
most neurodegenerative conditions is intra-cellular or extra-cellular deposition 
of pathologically aggregated proteins. These pathological deposits include 
beta-amyloid (β-amyloid) in the case of Alzheimer disease (AD), Tau in the 
case of AD and frontotemporal lobar degeneration (FTLD), TAR DNA binding 
protein of 43 kDa (TDP-43) in the case of amyotrophic lateral sclerosis, FTLD, 
fused in sarcoma in the case of FTLD, and Huntingtin in the case of 
Huntingtin’s disease. Emerging evidence suggests that epigenetic 
mechanisms contribute to the deposition of these pathological aggregates, 
and to pathways leading to neuronal death and/or cognitive and motor 
dysfunction downstream of the pathological deposits (reviewed in 
(Jakovcevski and Akbarian, 2012; Landgrave-Gómez et al., 2015)). Here, AD 
is used as a prototype neurodegenerative condition to discuss the contribution 
of different epigenetic mechanisms in brain degeneration.  
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AD is one of the most common neurodegenerative diseases worldwide with 
an estimated prevalence of 5-7% above the age of 60 years in most world 
regions (Prince et al., 2013).  AD pathology is characterized by two major 
hallmarks in the brain: extracellular amyloid plaques and intracellular 
neurofibrillary tangles (NFTs) (LaFerla and Kitazawa, 2005). Amyloid plaques 
are deposits of the amyloid β (Aβ) peptide, produced through enzymatic 
cleavage of the amyloid precursor protein (APP) by β and γ secretases. NFTs 
are intraneuronal aggregates of hyperphosphorylated tau, a microtubule-
binding protein (reviewed in (Serrano-Pozo et al., 2011)). E4 polymorphism of 
apolipoprotein E, a cholesterol carrier protein with additional roles in Ab 
metabolism and transport across the blood brain barrier, is the largest known 
genetic risk factor for late-onset AD (75).   
 
Epigenetic mechanisms have been extensively studied in the CdK-p25 mouse 
model of AD. Cyclin dependent kinase 5 (Cdk5) and its regulatory subunit p35 
are important for CNS development. p25, a truncated form of p35, increases 
Cdk5 activity, leading to tau hyperphosphorylation, formation of NFTs, 
astrogliosis and neurodegeneration (Patrick et al., 1999). Studies on CdK-p25 
AD model implicated altered histone PTMs in AD (78-81).  
 
Histone PTMs, especially aberrant histone acetylation may contribute to AD 
through an interaction of the components of APP-Aβ pathway and histone 
acetylation machinery in neurons. Both hyper and hypoacetylation have been 
reported in AD. Hyperacetylation is in part related to APP-Ab dependent 
regulation of HATs. APP intracellular domain, which is produced from APP by 
γ secretase, forms a complex with the nuclear adaptor protein Fe65 and the 
HAT TIP60 to activate transcription of genes (Cao and Südhof, 2001). Further, 
presenilin 1 (PS1), a gene coding for the γ secretase complex, may itself 
contribute to histone hyperacetylation in AD pathology. Loss-of-function 
mutations in PS1 or mutations associated with familial AD inhibit the 
proteasomal degradation of the HAT CREB binding protein (CBP), and result 
in increased CREB-mediated gene expression in cultured neurons 
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(Marambaud et al., 2003). Consistent with the involvement of 
hyperacetylation, overexpression of the HDAC SIRT1 (silent mating type 
information regulation 2 homolog 1) in CdK-p25 mice confers substantial 
protection against AD-related pathologies and memory loss (Kim et al., 2007).  
 
In contrast, other lines of evidence suggest that AD is associated with histone 
hypoacetylation related to a decreased activity of HATs or an increase in 
HDACs. In cultured cortical neurons, the overexpression of APP decreases 
H3 and H4 acetylation by reducing the level of CBP (Rouaux et al., 2003). 
Similarly, loss-of-function mutations in PS1 and PS2 genes in mice reduce the 
expression of CBP, as well as CBP/CREB target genes c-fos and BDNF 
(Saura et al., 2004). Further, HDAC2 is significantly increased in hippocampal 
CA1 neurons in an AD mouse model, which correlated with decreased 
promoter acetylation and expression of many plasticity related genes. Virus-
mediated knock-down of HDAC2 increases the expression of these genes, 
and improves cognitive functions in these mice, indicating that HDAC2 
induces an epigenetic blockade on cognitive functions in AD. This blockade 
can be induced not only by Ab oligomers but also by other neurotoxic stimuli, 
such as hydrogen peroxide, and depends on the binding of stress elements to 
HDAC2 promoter (Gräff et al., 2012b). Moreover in CdK-p25 AD mice, the 
intracerebroventricular injection of sodium butyrate, a potent class I/II HDAC 
inhibitor, rescues memory loss and reinstates synaptic connectivity (Fischer et 
al., 2007). Components of APP-Ab pathway can themselves be regulated by 
histone PTMs. For example, cellular models of AD show increased histone 
acetylation of PS1 and BACE1, and increased expression of HAT p300 (Lu et 
al., 2014). Similarly, apolipoprotein E4, which increases the risk of AD, favors 
the nuclear translocation of histones in human neurons, and reduces BDNF 
expression through low-density lipoprotein receptor related protein (Sen et al., 
2015). 
 
Changes in histone in AD are not limited to acetylation but also include altered 
methylation and ubiquitination, as observed in the frontal cortex of AD patients 
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(Anderson and Turko, 2015). These changes may contribute to AD by 
regulating Tau deposition, or by mediating neurotoxicity downstream to 
pathological Tau aggregation. Phosphorylation and acetylation of Tau inhibit 
its physiological binding and stabilization of neuronal microtubules, and 
instead promote tau insolubility and aggregation (Cohen et al., 2011; Gong et 
al., 2000).  Further, mimic of Tau Lys 280 acetylation exacerbates human 
Tau-mediated neurotoxicity in Drosophila (Gorsky et al., 2016). In contrast, 
histone lysine methylation occurs endogenously in normal human brains, and 
resists tau aggregation in vitro (Funk et al., 2014). Interestingly, a recent study 
showed that Tau protein has intrinsic HAT activity, and can self-acetylate 
(Cohen et al., 2013). This observation may explain why overexpressing Tau 
leads to Tau pathological aggregation, and questions the utility of HDAC 
inhibitors in Tau models of AD and other taupathies. 
 
Further to histone PTMs, DNA methylation and hydroxymethylation might also 
be involved in the pathology of AD. In general, global levels of DNMT and TET 
enzymes in AD brain regions, and the presence of their reaction products, 
5mC and 5hmC, have been investigated in several studies. AD patients have 
decreased levels of 5mC and DNMT1 in neurons of the entorhinal cortex 
(Mastroeni et al., 2010). Similarly, a global reduction of 5mC and 5hmC is 
observed in the hippocampus of AD patients (Chouliaras et al., 2013). 
Another study however, reported opposite results with increased level of 5mC, 
5hmC and TET1 in hippocampal tissue (Bradley-Whitman and Lovell, 2013). 
In the frontal and temporal cortex of AD patients, both 5mC and 5hmC are 
elevated (Coppieters et al., 2014). Further analyses are therefore required to 
understand these discrepancies. Gene-specific alterations in DNA methylation 
have also been identified in AD patients. A postmortem study in humans 
reported hypomethylation of the presenilin promoter region in late-onset AD 
patients when compared to age-matched healthy subjects (Wang et al., 
2008). Furthermore, in vitro hypomethylation of the promoter region of PS1 
increases presenilin expression, which enhances β-amyloid formation (Scarpa 
et al., 2003). This effect can be reversed by application of the methyl donor S-
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adenosylmethionine (SAM) that rescues methylation, decreases presenilin 
expression and reduces β-amyloid formation. These observations suggest 
that methyl donors or drugs targeting the methyl metabolism may be potential 
therapeutic agents to treat AD (Scarpa et al., 2006). 
 
In contrast, other AD-related susceptibility genes such as BACE1, which 
codes for β-secretase, or the gene coding for apolipoprotein E are 
hypermethylated in late-onset AD (Wang et al., 2008). This suggests that 
DNA methylation is presumably altered bidirectionally and in a gene-specific 
manner in AD, similar to histone acetylation. Recently, two independent 
epigenome-wide association studies identified genome-wide DNA methylation 
profiles from brain tissue of patients with AD (De Jager et al., 2014; Lunnon et 
al., 2014). These studies uncovered site-specific methylation alterations and 
expression changes in genes not previously associated with AD. In particular, 
four novel loci were independently identified, underpinning their likely 
association with AD risk. Furthermore, AD-associated genes and genes 
important for neuronal functions are differentially hydroxymethylated in the 
hippocampus of a mouse model of AD as demonstrated via 5-hmC genome-
wide profiling (Shu et al., 2016). This study further showed that treatment of 
culture hippocampal neurons with toxic Aβ (1-42) peptide decreases global 5-
hmC expression. Further studies are, however, needed to identify the 
alterations in DNA methylation and hydroxymethylation at specific genes and 
their possible effect on gene expression to better characterize the 
mechanisms underlying AD pathogenesis. 
 
MiRNAs may contribute to AD pathology by post-transcriptionally regulating 
the expression of proteins involved in the production or clearance of amyloid-
b. For example, BACE1 expression can be regulated by miR-195 (Zhu et al., 
2012), miR-188 (Zhang et al., 2014), and miR-339-5p (Long et al., 2014). 
Similarly, miR-153 suppresses the expression of APP (Long et al., 2012). In 
addition to amyloid production, proteins important for amyloid clearance 
across the blood-brain barrier, such as receptor for advanced glycosylation 
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end products can also be regulated by miRNAs (Mercado-Pimentel et al., 
2015). Further, miRNAs are also involved in the production of Tau, the major 
component of neurofibrillary tangles. Tau expression is under the control of 
miR- 219 (Santa-Maria et al., 2015). Similarly, miR-125b (Banzhaf-
Strathmann et al., 2014), miR-26b (Absalon et al., 2013), and miR-922 (Zhao 
et al., 2014) induce Tau phosphorylation by regulating Tau-related kinases 
and phosphatases, which correlates with cognitive deficits in AD models. 
Finally, miRNAs may link amyloid/tau deposition to pathways responsible for 
neuronal death and/or cognitive deficits in AD. Cognitive deficits in an AD 
transgenic model were related to miR-206-dependent dysregulation of BDNF 
(Lee et al., 2012). Similarly, another study showed that oxidative damage 
produced by soluble Ab peptide is likely mediated by altered expression of 
miR-145 and miR-210 (Li et al., 2014a). Finally, miR-146a arbitrates the 
inflammatory circuits in AD models and stressed human brain cells through 
nuclear factor kappa-light-chain-enhancer of activated B cells NFkB (Lukiw et 
al., 2008). 
 
In conclusion, it is becoming increasingly clear that epigenetic processes are 
implicated in AD at multiple levels. They mediate the effects of AD risk factors, 
regulate the expression of many proteins involved in amyloid production 
and/or clearance, block cognitive functioning in AD, and are responsible for 
neuronal death downstream from pathological Aβ/Tau aggregation. Some 
epigenetic marks like histone acetylation are currently being investigated as 
biomarkers in AD (Wey et al., 2016) and HDAC inhibitors for potential 
therapeutic approaches. However, the widely used non-specific HDAC 
inhibitor valproic acid could not reverse cognitive decline or neuropsychiatric 
symptoms associated with AD in a double-blind place-controlled trial (Tariot et 
al., 2011). More selective inhibitors may have better outcomes (Falkenberg 
and Johnstone, 2014). The involvement of epigenetic mechanisms in 
mediating the risk of AD also highlights their implication in AD prevention, 
particularly in selected groups. Of particular note here are dietary factors, 
environment enrichment, and exercise, as they all have potential to change 
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gene expression epigenetically, and have been shown to delay/ameliorate the 
symptoms of AD. Emerging evidence suggests that certain diets and exercise 
can have protective effects in AD through possible epigenetic regulation of 
BDNF. Similarly, polyphenols in diet have the potential to counteract miRNAs 
alterations induced by apolipoprotein E knock-out, indicating their potential for 
delaying AD in individuals with apolipoprotein E4 polymorphism (Dauncey, 
2013, 2014, 2015).  
 
2.2.4 Epigenetic dysregulation in psychiatric disorders - The 
example of depression 	  
Psychiatric diseases like depression and personality, anxiety or psychotic 
disorders are multi-faceted conditions with complex etiology, and are often 
difficult to treat. A substantial body of evidence suggests that depressive 
phenotypes are partly caused by epigenetic mechanisms (see Figure 2.2).  
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Figure 2-2 The importance of posttranslational histone modifications 
(PTMs), DNA methylation and miRNAs in depression. (a) Alterations in 
histone PTMs. Upon chronic social defeat stress, a rodent model of 
depression, H3K27 dimethylation is increased at Bdnf promoter. This leads to 
chromatin condensation, which shuts down Bdnf gene expression. In parallel, 
global H3 acetylation levels are decreased, accompanied by increased 
HDAC5 expression. Chronic antidepressant (imipramine) treatment reduces 
HDAC5 levels, leading to increased H3 acetylation, whereas H3K27 
dimethylation remains unaffected. Nonetheless, the increase in H3 acetylation 
is sufficient to reinstate Bdnf gene expression. (b) Alterations in DNA 
methylation. Depression in humans is associated with increased DNMT 
expression in the brain and differential methylation levels at several candidate 
gene promoters such as Bdnf. The increase in 5-methylcytosine levels at the 
Bdnf promoter correlates with low Bdnf expression in patients suffering from 
depression. Antidepressant treatment of blood cells from depressed 
individuals (paroxetine) results in reduced DNMT1 activity, decreased Bdnf 
methylation, which leads to increased Bdnf expression. (c) Alterations in 
miRNA profiles. Depression-like behaviors in rats induced by maternal 
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deprivation are associated with increased miR-16 expression, a miRNA that 
targets Bdnf, in the hippocampus, as well as, reduced Bdnf transcripts. In the 
blood of individuals with depression, the level of miR-1202 is reduced, while 
antidepressant treatment reverses this effect. 	  
According to DSM-V, major depressive disorder (MDD) is characterized by 
low mood, markedly diminished interest or pleasure in activities, fatigue or 
lethargy, feelings of worthlessness or excessive guilt, psychomotor agitation 
or retardation, and abnormal weight or sleep changes (American Psychiatric 
Association). This chronic illness affects a sizable population with about 1.5% 
to 19% life-time prevalence worldwide (Kessler and Bromet, 2013; Weissman 
et al., 1996). Depression is difficult to treat, and only half of depressed 
patients show complete remission (Berton and Nestler, 2006; Tsankova et al., 
2007). A major issue with most treatments is that the symptoms are usually 
ameliorated only after a few weeks of therapy. The reasons for such delay are 
not entirely known but could reflect the contribution of epigenetic mechanisms 
to the etiology of depression. Epigenetic mechanisms are also implicated in 
the appearance of depression after stress exposure, and in the effect of anti-
depressants (Menke and Binder, 2014).  
The importance of histone PTMs in depression can be appreciated from a 
rodent model of social defeat. This model of chronic stress induces symptoms 
of depression that can be reversed with long-term antidepressant treatment, 
mimicking the observation in humans (Tsankova et al., 2006). In mice, chronic 
social defeat decreases the expression of two splice variants of Bdnf in the 
hippocampus and induces H3K27 dimethylation, a mark for transcriptional 
repression (Kouzarides, 2007), in their respective promoter regions (Tsankova 
et al., 2006). While behavioural anomalies induced by social defeat are 
reversed by chronic antidepressant treatment, the increase in H3K27 
dimethylation is not (Tsankova et al., 2006).  
 
Instead, H3 acetylation and H3K4 methylation, marks of transcriptional 
activation (Kouzarides, 2007), are increased at the same promoters leading to 
a reversal of Bdnf downregulation (Tsankova et al., 2006; Wilkinson et al., 
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2009). Long-term antidepressant treatment also down-regulates the 
expression of HDAC5 in animals exposed to chronic stress (Renthal et al., 
2007). Thus, changes in histone acetylation and methylation by chronic stress 
at the Bdnf gene in the hippocampus are likely important for the development 
of depressive behaviours, and histone acetylation is a target of antidepressant 
treatments. Further, chronic unpredictable mild stress (CUMS) also decreases 
H3K9 methylation at the promoter of corticotrophin-releasing hormone 
receptor 1 in the rat hippocampus, and is associated with altered 
hypothalamic-pituitary-adrenal axis, a characteristic of depression (Wan et al., 
2014). Further to the hippocampus, other neuroanatomical regions have 
changes in histone PTMs at genes involved in behavioural response to 
chronic stress. In ventral striatum, histone PTMs at glial-derived neurotrophic 
factor gene have been associated with the susceptibility and adaptation to 
chronic stress in mice (Uchida et al., 2011).  
 
Alterations in DNA methylation have been reported upon antidepressant 
administration in preclinical and clinical studies. In a rat model of depression, 
three-week treatment with the selective serotonin re-uptake inhibitor (SSRI) 
escitalopram reduced mRNA levels of DNMT1 and DNMT3a in forebrain 
neurons associated with decreased global DNA methylation and partial 
reversal of pro-depressant behaviors  (Melas et al., 2012). 
Consistently, hypomethylation of the serotonin transporter gene, a main target 
of SSRIs, affects SSRI treatment response in humans (Domschke et al., 
2014). Intraperitoneatal administration of the SSRI fluoxetine leads to 
increased MeCP2 and methyl CpG-binding domain protein 1 (MBD1) in the 
adult rat brain (Cassel et al., 2006). Typically, both methyl-binding proteins 
are enriched in neurons, as compared to glial cells (Zachariah et al., 2012; 
Zhao et al., 2003). Upon fluoxetine administration, both proteins were found to 
accumulate in neurons, including GABA-ergic interneurons. This is of 
particular interest because abnormal GABA-ergic transmission and anomalies 
in GABA-related gene methylation are linked to major depression and suicide. 
Depressed patients who committed suicide have higher level of methylation in 
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the GABA-A α1 receptor subunit promoter, and increased DNMT3b mRNA 
and protein in the prefrontal cortex when compared to control individuals who 
died of other causes (Poulter et al., 2008). This suggests the interesting 
possibility that antidepressant treatments can target the epigenetic machinery 
in cell types affected by depression. Several studies further reported 
differential DNA methylation at candidate genes such as Bdnf in different 
tissues of depressed individuals. Increased 5-mC level at Bdnf promoter IV is 
associated with decreased Bdnf transcript levels in Wernicke’s area of suicide 
victims, some of whom suffering from MDD (Keller et al., 2010). This suggests 
that changes in DNA methylation levels could be responsible for Bdnf down-
regulation in depression. Bdnf promoter hypermethylation is observed in both 
buccal tissue and blood of depressed patients, and is correlated with suicidal 
behaviour. Treatment of peripheral blood cells isolated from depressed 
patients with the antidepressant paroxetine reduces DNMT1 activity and Bdnf 
methylation, and correlates with increased Bdnf expression (Gassen et al., 
2015). Bdnf methylation may therefore serve as a biomarker for the diagnostic 
of MDD (Fuchikami et al., 2011; Januar et al., 2015; Kang et al., 2013). 
Genome-wide profiling of DNA methylation may also be useful since profiling 
in blood of patients suffering from depression is distinct from non-depressed 
individuals (Uddin et al., 2011). But DNA methylation profiling can be variable 
as revealed by analyses in monozygotic twins from depression-discordant 
pairs (Byrne et al., 2013; Cordova-Palomera et al., 2015; Davies et al., 2014; 
Dempster et al., 2014), suggesting the possibility that the methylome of 
patients with MDD may be more sensitive to environmental influence. Further, 
miRNAs have also been associated with the long-term effects of chronic 
stress, an important precursor of depression. Chronic mild stress alters the 
expression of miR-186 and miR-709 in the hippocampus and pre-frontal 
cortex in mice (Babenko et al., 2012). miR-19b may mediate the pro-
depressive effects of chronic stress by decreasing the expression of 
adrenergic receptor b1 in BLA (Volk et al., 2014). A possible mode of action of 
miRNAs is to regulate the molecular pathways underlying stress resilience. 
MiR-135 is considered an endogenous “anti-depressant” which has been 
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shown to prevent the development of pro-depressive phenotype in mice by 
modifying serotonergic activity (Issler et al., 2014). Further, miRNAs can 
contribute to the regulation of neurogenesis (miR-124 through targeting Sox9; 
miR-128 through targeting LRRC4C), neurotrophic signalling (miR-26 a and b 
through targeting BDNF) and inflammation (miR-155 and miR-181), which 
have all been implicated in depression (Dwivedi, 2014; Hutchison et al., 2013; 
Woodbury et al., 2015). Not surprisingly, clinically efficient anti-depressants 
lead to notable changes in brain miRNA profiles. For example, fluoxetine 
promotes the biogenesis of miR-16 in raphe nuclei (Baudry et al., 2010), and 
imipramine and citalopram regulate miR-1202 (Lopez et al., 2014). 
 
In conclusion, the contribution of epigenetic mechanisms to molecular 
pathways affected by stress, their role in determining the susceptibility to 
depression, and their alteration by anti-depressants, highlight their potential 
role in depressive prophylaxis and therapeutics. It is also possible that non-
pharmacological strategies like cognitive behavioural therapy and 
psychotherapy used to treat depression also implicate epigenetic changes. A 
recent study showed that response to psychotherapy in patients with 
borderline personality disorder decreased CpG methylation at two exons of 
BDNF, BDNF CpG exon I and IV in peripheral blood leukocytes, whereas 
methylation was increased in non-responders (Perroud et al., 2013). This 
supports the idea that epigenetic marks are amenable to non-pharmacological 
treatment approaches in psychiatry, and could serve as therapeutic targets, 
and prognostic markers in the future. Off note again here is the potential of 
dietary factors and exercise in prevention and/or treatment of psychiatric 
disorders. Changes in serotonergic signalling by Tryptophan-rich diets, 
exercise-induced changes in BDNF and induction of neurogenesis are a few 
ways through which diet and exercise could alter the development or clinical 
course of depression (Dauncey, 2013, 2014).  
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2.2.5 Epigenetic dysregulation by environmental stress - the 
example of early life stress 
 
It has long been recognized that detrimental experiences in early postnatal life 
have long-lasting consequences for brain functions, especially in the affective 
domains. The quality of the social and parental environment early postnatal in 
particular, is a critical determinant of an organism’s neuropsychological 
development. In humans, childhood trauma or prolonged separation from the 
mother results in deviant behaviors such as drug abuse, in adult life (Khoury 
et al., 2010). In mice, unpredictable maternal separation combined with 
unpredictable maternal stress was also shown to lead to severe and 
persistent emotional and cognitive dysfunctions (Franklin et al., 2010). Such 
adverse experiences in early postnatal life are known to induce multiple 
epigenetic modifications in the brain, resulting in altered gene expression 
(reviewed in (Kundakovic and Champagne, 2015)). Different molecular factors 
including glucocorticoids and glucocorticoid receptor (GR), mineralocorticoid 
and mineralocorticoid receptor (MR), arginine vasopressin (AVP) and oxytocin 
are noteworthy are known to be altered by early traumatic stress.  
 
Maternal care is indeed an important environmental factor for behavioral 
responses later in life. The offspring of high-nurturing female rat have 
decreased DNA methylation and increased H3K9 acetylation at NR3C1, a 
gene coding for GR, in the brain (Weaver et al., 2004). In contrast, the 
offspring of low nurturing females have decreased brain NR3C1 methylation, 
suggesting that differential epigenetic marking underlies changes in GR 
expression by maternal care. In humans, childhood maltreatment and 
adversity also lead to alterations of DNA methylation at NR3C1 as observed 
in the hippocampal autopsy specimens of suicide victims with a history of 
childhood abuse (McGowan et al., 2009). Importantly, methylation profile at 
NR3C1 promoter in response to early life trauma is comparable in rats and 
humans (Suderman et al., 2012). It is not surprising that epigenetic regulation 
of GR Is under stringent regulation considering its critical role in mediating the 
effect of stress on the brain, and serving as an important determinant of 
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neuro-endocrine integration (Woodbury et al., 2015). Likewise, disrupted 
maternal care in early childhood decreases hippocampal MR expression in 
adults in association with changes in histone PTMs (Gapp et al., 2014). 
Parental contact in early postnatal life also determines DNA methylation of 
oxytocin gene in the brain and the periphery of the offspring in rodents 
(Hammock, 2015). Finally, periodic mother-infant separation in mice leads to 
DNA hypomethylation in the promoter region of AVP, which correlates with an 
increased and persistent expression of AVP resulting in increased 
vulnerability to stress in adulthood (Hammock, 2015; Kember et al., 2012). 
Such persistent increase in avp could have pleiotropic effects on adult brain 
functions related to its role in regulation of social behaviors, pair bonding, 
sexual preferences, and its noted dysregulation in anxiety and depression 
(Meyer-Lindenberg et al., 2011). 
 
Genome-wide CpG promoter methylation screen revealed differentially 
methylated regions in post-mortem hippocampal tissue of suicide victims with 
a history of childhood abuse. These changes are associated with the 
dysregulation of a network of genes involved in neuronal plasticity (Labonté et 
al., 2012). In adult monkey, early-life maternal deprivation is associated with 
changes in DNA hydroxymethylation at the promoter of genes related to 
psychiatric disorders and/or perinatal adversity in cortex (Massart et al., 
2014). In maternally deprived animals, hydroxymethylation was decreased at 
the promoter of the dopaminergic receptor 3, the adrenoreceptor alpha 1, and 
the serotonergic transporter. In contrast, hydroxymethylation was increased at 
the promoter of the GABAA receptor alpha 2, the transcriptional repressor 
REST and the MAP kinase 1. Hydroxymethylation within promoter regions has 
been hypothesized to constitute an epigenetic mark presumably associated 
with transcriptional modulators (Cartron et al., 2013; Mellen et al., 2012). It 
should be noted however, that further studies are required to fully understand 
its functional implications. Altogether, these findings suggest that early life 
adversity triggers variations in both DNA methylation and hydroxymethylation 
that persist into adulthood.  
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Besides DNA methylation, miRNAs may also be important mediators of the 
effects of early postnatal environmental influence, since several of them are 
affected by early adversity. miR-16 expression is increased in the rat 
hippocampus after early life trauma, leading to decreased hippocampal BDNF 
(Bai et al., 2012). Maternal deprivation in early childhood also alters miR-504 
expression in nucleus accumbens in rats (Zhang et al., 2013c).  
 
Epigenetic modifications can carry the effects of early life trauma not only 
through life but also across generations. Exposure to early life trauma induced 
by unpredictable maternal separation and unpredictable maternal stress has 
been shown to alter behavior and metabolism across generations, even in the 
absence of any traumatic exposure in the offspring. Transmission of these 
effects implicates sperm RNAs since sperm RNAs from traumatized males 
injected into naïve control fertilized oocytes recapitulate the effects of trauma 
in the resulting animals. These RNAs include miRNAs, which expression is 
altered by trauma not only in sperm, but also in the serum and brain of 
exposed mice, and in the brain of the offspring (Gapp et al., 2014). Apart from 
miRNAs, early life trauma also alters DNA methylation in sperm and brain 
across generations. It alters DNA methylation in several genes, such as 
corticotropin-releatsing factor receptor 2 and cannabinoid receptor 1, 
associated with depressive-like behaviors, in the brain and the sperm of 
exposed males and their offspring (Franklin et al., 2010), suggesting another 
potential means of transgenerational epigenetic inheritance. Such epigenetic 
alterations were recently shown to be reversed by environmental or 
pharmacological manipulations. Cross-fostering of pups, or treatment with the 
HDAC inhibitor trichostatin A leads to NR3C1 DNA hypomethylation and 
histone hyperacetylation in the offspring of low nurturing mothers (Weaver et 
al., 2004). Likewise, methyl supplementation via administration of L-
methionine, a SAM precursor, can reverse maternal programming of stress 
responses via GR (Weaver et al., 2005). Importantly, sub-optimal maternal 
care also decreases histone acetylation of a large number of genes in the 
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mouse hippocampus, including ATRX and Reelin, and these changes are 
reversed by treatment with trichostatin A. (Weaver et al., 2006). Finally, 
paternal environmental enrichment also reverses the transmission of 
behavioral traits, and corrects aberrant DNA methylation of NR3C1 in a 
mouse model of early life trauma (Gapp et al., 2016).  
 
Future research on this immensely intriguing topic should focus on the 
effectors of these epigenetic changes, and on identifying the mechanisms 
underlying the effects of early life-trauma on the brain and the germ-line. 
Circulating hormones and cytokines could be relevant as they can readily 
access the brain and germ cells. Indeed, maternal immune activation 
mediates the transgenerational effects of prenatal stress (Weber-Stadlbauer 
et al., 2016). Further, the observation that environmental enrichment can 
reverse some of the long-term adverse consequences of early postnatal 
trauma through epigenetic modulation also raises the question if dietary 
factors could have similar preventive or therapeutic benefits. Influence of 
folate-containing diet to modulate DNA methylation, tryptophan-rich diet to 
modify serotonergic signaling in the brain, and anti-oxidant and anti-
inflammatory properties of certain foods are important to consider (Dauncey, 
2013, 2014, 2015). Although the field is extremely dynamic and the subject of 
considerable research, more pre-clinical and clinical research will be needed 
for applying these findings to the clinic.  
 
2.3 Conclusions and outlook  
 
It is becoming increasingly clear that epigenetic mechanisms play a pivotal 
role in higher-order brain functions, in both physiological and pathological 
conditions. Epigenetic mechanisms contribute to the etiopathology of brain 
disorders, determine an individual’s disease susceptibility, and underlie the 
therapeutic efficacy of treatments. In some cases, epigenetic mechanisms 
serve as vectors carrying the effects of environmental stressors to subsequent 
generations. A precise delineation of these processes is necessary for a 
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better understanding of the mechanisms underlying brain diseases, and for 
the development of potential treatments and preventive strategies. Future 
research should therefore explore how epigenetic mechanisms contribute to 
the risk to or protection against brain disorders. Possible cross-talks between 
epigenetic mechanisms such as regulation of HDACs or DNMTs binding by 
ncRNAs, or potential master epigenetic regulators and functional ‘epigenetic 
codes’ should be identified. Further to DNA methylation, histone PTMs, and 
miRNAs, other forms of epigenetic regulation such as long non-coding RNAs, 
piwi RNAs (piRNAs), RNA methylation or prion-like mechanisms may also be 
involved. Long non-coding RNAs were found to be altered in mouse models of 
AD (Lee et al., 2015) and depression (Huang et al., 2016). Similarly, piRNAs 
have emerged as critical vectors of inter-generational inheritance in C. 
elegans and Drosophila, and as regulators of long-term memory in mice 
(Ashe et al., 2012; Rajasethupathy et al., 2012). These processes merit 
attention in the future. 
 
It is also important to consider and when possible solve the issue of the use of 
epigenetic treatments for brain disorders. The complexity of the epigenetic 
landscape in the brain, and of its regulation in different brain cell types during 
development and adulthood, with constant interaction with the environment 
needs to be carefully studied (Szyf, 2015). Additional challenges include the 
possibility that manipulating an epigenetic effector could have contrasting 
effects in different brain regions and/or functions, or in the periphery (Szyf, 
2015). A relevant example is that of the miRNA cluster miR183-96-182, which 
promotes memory formation when over-expressed in the mouse hippocampus 
(Woldemichael et al., 2016), but has also been linked with depressive-like 
behavior in rat (Li et al. Prog Neuropsychopahrm Biol Psych 2016). An 
additional challenge is the low permeability of the blood-brain barrier. Some of 
the challenges of using epigenetic drugs to treat brain diseases need to be 
addressed in the future, and consider the mode of regulation of epigenetic 
enzymes and their targets in different brain cells, neuroanatomical regions, 
and functional contexts. It would also be important to determine if epigenetic 
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therapies are more likely to benefit selected groups based on genetic features 
like the presence or absence of metabolizing enzymes, in which case those 
groups would need to be carefully isolated through genetic screening and/or 
clinical histories.    
 
In summary, the importance of epigenetic dysfunction in brain diseases is now 
fully appreciated. With a better understanding of their modes of regulation and 
the identification of their specific downstream targets, and their region and 
cell-type specific effects, safe and efficient epigenetic treatments can be 
envisaged for treatment of brain disorders in future.   
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3.1 Abstract 	  
5-hydroxymethylation (5-hmC) is an epigenetic modification on DNA that 
results from the conversion of 5-methylcytosine by Ten-Eleven Translocation 
(TET) proteins. 5-hmC is widely present in the brain and is subjected to 
dynamic regulation during development and upon neuronal activity. It was 
recently shown to be involved in memory processes but currently, little is 
known about how it is controlled in the brain during memory formation. Here, 
we show that Tet3 is selectively up-regulated by activity in hippocampal 
neurons in vitro, and after formation of fear memory in the hippocampus. This 
is accompanied by a decrease in miR-29b expression that, through 
complementary sequences, regulates the level of Tet3 by preferential binding 
to its 3’UTR. We newly reveal that SAM68, a nuclear RNA-binding protein that 
regulates splicing, acts upstream of miR-29 by modulating its biogenesis. 
Together, these findings identify novel players in the adult brain necessary for 
the regulation of 5-hmC during memory formation. 
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3.2 Author summary 
 
 
DNA hydroxymethylation is mediated by the family of Ten-Eleven 
Translocation (TET) proteins comprising TET1, 2 and 3, and is associated 
with transcriptional gene regulation. Recent studies have suggested a role for 
TETs in the epigenetic regulation of gene expression during memory 
formation. However, the mechanisms of such regulation remain unknown. 
MicroRNAs are short non-coding RNAs that regulate gene expression 
transcriptionally and/or translationally, and provide a rapid and reversible 
mode of control. Here, we show that both, Tet3 and the miR-29 cluster are 
differentially regulated, in an opposite manner, in the hippocampus after 
learning, and in cultured hippocampal neurons upon activity. MiR-29b, one 
member of the cluster, binds to the 3’UTR of Tets and controls their mRNA 
level, but has a preference for Tet3. We identify a novel regulator of the 
biogenesis of miR-29 cluster, the RNA-binding protein SAM68, and show that 
it controls the transcription of the cluster. These findings reveal a new 
cascade involving SAM68, miR-29 cluster and TET3 in the epigenetic 
regulation of memory genes after learning.  	  	  
3.3 Introduction 
 
Epigenetic mechanisms involving DNA methylation are essential for the 
regulation of gene expression in the brain, and are required for learning and 
memory formation (Levenson and Sweatt, 2005). Until recently, DNA 
methylation was believed to be stable in post mitotic cells, but it is now known 
to be dynamically regulated at specific sites upon neuronal stimulation and 
learning (Guo et al., 2011b; Ma et al., 2009; Miller and Sweatt, 2007), 
indicating that it is reversible. While DNA methyltransferases (DNMTs) 
catalyze DNA methylation on position 5 of cytosines (5-methylcytosine or 
5mC), ten-eleven translocation methylcytosine dioxygenases (TETs) are 
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responsible for DNA demethylation. TET proteins (TET1, 2 and 3) allow 
demethylation by converting 5mC into 5-hydroxymethylcytosine (5hmC). TETs 
can further oxidize 5hmC into 5-formylcytosine and 5-carboxylcytosine that is 
subsequently excised by the base excision repair pathway (Ito et al., 2011). 
5hmC accumulates in the brain during development and is present at high 
level in the adult brain, suggesting that it likely plays an important role 
(Szulwach et al., 2011). Like DNA methylation, it is dynamically regulated by 
neuronal activity (Guo et al., 2011c) but the mechanisms that allow its 
dynamic regulation are not known.  
 
TET1 is the best-characterized enzyme among the TET family with regard to 
learning and memory. Tet1 mRNA was shown to be downregulated 1 and 3 
hours after contextual and cued fear conditioning in area CA1 of the dorsal 
hippocampus (Kaas et al., 2013). TET1 regulates the expression of several 
activity-dependent genes implicated in learning and memory and its 
overexpression in the hippocampus impairs long-term associative memory [8]. 
However, global TET1 knockout in mice does not alter memory acquisition 
and consolidation, but selectively impairs the extinction of hippocampus-
sensitive memories (Rudenko et al., 2013). It also affects neurogenesis 
(Zhang et al., 2013b) and long-term depression in the hippocampus (Rudenko 
et al., 2013).  
 
Less is known about the role of TET3 in memory processes. However, in the 
cortex and hippocampus, two brain regions essential for learning and 
memory, Tet3 is the most highly expressed enzyme of the TET family 
enzymes (Szwagierczak et al., 2010). Tet3 but not Tet1 mRNA increases 2 
hours after extinction training in prefrontal cortex, a structure critical for 
memory extinction (Li et al., 2014b). Tet3 mRNA increases 2 hours after 
extinction training in the prefrontal cortex, and knockdown of Tet3 in this 
region impairs memory extinction, without affecting learning (Li et al., 2014b). 
Thus, TETs might have various roles in memory processes depending on the 
brain region, and possibly the type of memory. 
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The modes of regulation of TETs remain unknown but microRNAs (miRNAs) 
have been thought as potential candidates. miRNAs are short non-coding 
RNAs that can control neuronal gene expression required for memory 
formation. The biogenesis, rapid turnover and combinatorial modes of action 
of miRNAs make them ideal candidates for a dynamic and reversible 
regulation of gene expression (Ha and Kim, 2014). They can control multiple 
targets simultaneously through degradation of their mRNAs or translational 
repression. Some miRNAs have also been implicated in the regulation of DNA 
methylation directly by targeting Dnmts or indirectly by acting on transcription 
factors that control Dnmts transcription (Benetti et al., 2008)(Fabbri et al., 
2007). The miR-29 family (a, b and c), in particular, was shown to contribute 
to epigenetic regulation in cancer by targeting Dnmt3a and b (Fabbri et al., 
2007). Conversely, miRNAs themselves are subject to specific mechanisms of 
control. Their transcription, processing and degradation are regulated by 
different processes involving protein-protein and protein-RNA interactions 
(Krol et al., 2010b). In these mechanisms, RNA-binding proteins (RBPs) are 
very important regulators implicated in different stages of miRNAs biogenesis, 
localization, activity and degradation. SAM68 (also called KHDRBS1), is an 
RBP mostly known to regulate activity-dependent alternative splicing (Iijima et 
al., 2011), was recently shown to influence the expression of a subset of 
miRNAs in male germ cells (Messina et al., 2012). In this study, we provide 
evidence that the miR-29 family is differentially regulated in the adult 
hippocampus upon learning and that miR-29 biogenesis is modulated by 
SAM68. These miRNAs are involved in the control of Tets, in particular Tet3, 
which itself is regulated in an activity-dependent manner upon learning to 
induce 5hmC. 
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3.4 Results  
 
To determine the dynamics of TETs regulation upon neuronal activity in the 
adult brain, we quantified the level of Tet mRNAs in the hippocampus after 
contextual fear conditioning (CFC) (S1 Fig). While Tet1 and Tet2 mRNA 
remained unchanged after conditioning, Tet3 mRNA was up-regulated after 
30 min and 3 h but returned to baseline after 24 h (Fig 1a). To test whether 
the changes in Tet3 expression were specific to memory formation in CFC 
and were not related to the stress response elicited by fear conditioning, we 
examined the effects of acute cold swim stress on Tets expression in the 
hippocampus. C-fos, an activity-dependent immediate early gene, was used 
as positive control to ensure that neuronal activation occurred (S2a Fig). 
Importantly, Tet3 expression was not modified by cold swim stress (S2b Fig). 
Further, Tet3 expression was also up-regulated by activity in cultured 
hippocampal neurons in vitro. Neuronal activation by NMDA, confirmed by C-
fos expression (S3a Fig), significantly increased Tet3 expression after 5 min 
and 1 h (Fig 1b). It also slightly increased Tet2 expression after 1 h but 
decreased Tet1 after 5 min, suggesting a dissociated response of the three 
TETs. Consistently, C-fos, Tet2 and Tet3 but not Tet1 were also up-regulated 
by activation of NMDA receptors by the co-agonist glycine in vitro (S3b, c Fig). 
These findings suggest that NMDA receptor signaling increases Tet3 
transcription, both after neuronal activation in vitro and learning in vivo. 
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We next sought to identify which mechanisms participate to the control of Tet3 
mRNA level. In silico target gene prediction algorithms indicated that Tet 3’-
UTR has multiple well-conserved binding sites for miR-29 (TargetScan 
analysis, S1 Table). Therefore, we examined whether miR-29, a miR cluster 
including miR-29a, b and c, has a relation to Tets during CFC. While miR-29a 
and c remained constant, miR-29b expression was significantly down-
regulated 3 h after conditioning and following testing (Fig 2a). MiR-29b was 
Figure 3-1 Activity-dependent expression of Tet genes. (a) Level of Tet1, 2, 
and 3 in the hippocampus 30 min, 3 h, 24 h after fear conditioning, or 30 min after 
testing 24 h following conditioning, measured by real-time quantitative reverse 
transcription-PCR (RT-qPCR). (b) Level of Tet1, Tet2 and Tet3 in hippocampal 
primary neurons 5 min and 1 h after NMDA stimulation (60 μM, 5 min) measured 
by RT-qPCR. No cond., no conditioning; *p<0.05, **p<0.01. Data represent mean 
s.e.m. Supporting information can be found in S1 Fig, S2 Fig and S3 Fig. 
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also decreased 5 min and 1 h after NMDA stimulation in hippocampal 
neurons, while miR-29a and c expression decreased only after 1 h (Fig. 2b). 
Likewise, it was decreased after 5 min and 1 h of glycine treatment while miR-
29a and c were not (S4 Fig). These results suggest that miR-29b expression 
is activity-dependent and has an expression profile inverse to Tet3 after 
learning and neuronal activity. 
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Figure 3-2 Activity-dependent expression of miR-29 family. (a) Level of 
miR-29a, b and c in the hippocampus 30 min, 3 h, 24 h after fear conditioning, 
or 30 min after testing (24h after conditioning) measured by RT-qPCR. (b) 
Level of miR-29a, b and c in hippocampal primary neurons 5 min and 1h after 
NMDA stimulation (60 μM, 5 min) measured by RT-qPCR. No cond., no 
conditioning; *p<0.05, **p<0.01. Data represent mean s.e.m. Supporting 
information can be found in S4 Fig. 
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To test if miR-29b targets Tets, we manipulated its level in N2a cells using 
miRNA mimic or antagomir. Overexpression of a miR-29b mimic down-
regulated Tet1, 2 and 3 expression (Fig. 3a) while miR-29b knockdown 
increased Tet1 and 3 expression (Fig. 3b). Then, using two different regions of 
Tet3 3’-UTR (Tet3(1) and Tet3(2)) with seed sequences for miR-29 cluster (S5a 
Fig) and a luciferase reporter, we further examined the interaction between Tet3 
and miR-29b. MiR-29b mimic significantly reduced luciferase activity with both 
reporters (Fig. 3c), showing that miR-29b regulates the level of Tet3 mRNA 
likely by binding to its 3’UTR. Additionally, high doses of miR-29b mimic 
reduced the luciferase activity of Tet1 and Tet2 reporters (S5b Fig). 
 
To determine whether miR29b preferentially regulates Tet3, we tested the 
effect of graded concentrations of miR-29b mimic. While overexpression of 
miR-29b by mimic had no effect on the control vector (S6 Fig), it decreased 
the expression of Tet3 luciferase reporters in a dose-dependent manner. At 
low concentration (0.1 nM), the miR-29b mimic repressed Tet3 luciferase 
reporters but had no effect on Tet1 and Tet2, indicating a dose-dependent 
target regulation of miR-29b (Fig. 3d). Using STarMiR [19] to model mRNA 
secondary structure, we found that Tet3 3’UTR contains more accessible miR-
29b binding sites than Tet1 and Tet2 3’UTRs (S2 Table), providing a potential 
explanation for our experimental findings. As expected, miR-29b 
overexpression decreased Dnmt3a and b mRNA level as well as the 
luciferase activity of a Dnmt3a reporter (S7a, b Fig). However, Dnmt1 was not 
changed, consistent with the absence of binding sites for miR-29s in its 3’-
UTR (S7a Fig), confirming the specificity of the assay. 
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To further investigate the function of TET3, we examined the effects of Tet3 
knockdown on the expression of potential candidate genes. Using siRNAs 
specifically targeting Tet3 (Tet1 and 2 remained unchanged, S8 Fig), we 
identified genes involved in Notch signaling (Notch1 and 2), repair-based DNA 
demethylation (Gadd45a and b) and transcriptional activation (Elk1, Crebbp 
and Creb1) (Fig.4). Interestingly, all these genes were previously implicated in 
neuronal activity, synaptic plasticity and/or memory processes (Ahi et al., 
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Figure 3-3 MiR-29b preferentially controls Tet3 expression level. (a) Level of 
Tet1, Tet2, and Tet3 in N2a cells after transfection with miR-29b mimic or control 
measured by RT-qPCR. (b) Level of Tet1, Tet2, and Tet3 in N2a cells after 
transfection with miR-29b antagomir or control measured by RT-qPCR. (c) 
Analysis of Tet3 luciferase reporters in the presence of miR-29b mimic or control 
(60 nM) in N2a cells (d) Analysis of Tet1, Tet2 and Tet3 luciferase reporters in the 
presence of graded concentrations of miR-29b mimic or control in N2a cells. 
*p<0.05, **p<0.01, ***p<0.001. Data represent mean s.e.m. Supporting information 
can be found in S5 Fig, S6 Fig and S7 Fig. 
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2004; Dias et al., 2014; Sultan et al., 2012). In contrast, the expression of 
major components of the miRNA biogenesis (Drosha, Dgcr8, Dicer) and other 
microprocessor accessory proteins involved in the control of miRNA 
biogenesis such as p68, p72 and p53 were not altered by Tet3 knockdown 
(Fig. 4), indicating that TET3 does not affect global miRNA biogenesis. These 
results suggest that an intermediate molecular player is involved in 
modulating the expression of miR-29b upon neuronal activity.  
 
 
 
Previous work has identified that SAM68 – an RBP - influenced the 
expression of specific miRNAs in male germ cells, including miR-29b 
(Messina et al., 2012). RBPs play a role in the biogenesis of specific miRNAs 
(reviewed in (Loffreda et al., 2015)), thus we examined the potential link 
between SAM68 and its role in regulating the biogenesis of the miR-29 family. 
MiRNAs are produced through the action of multiple enzymatic steps involving 
the transcription of primary miRNAs (pri-miRNAs), their processing into 
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Figure 3-4 TET3 regulates the expression of synaptic and memory-
related genes.Transcriptional analysis of genes involved in synaptic 
plasticity, memory formation, and miRNA biogenesis after Tet3 knockdown 
in N2a cells by RT-qPCR. *p<0.05, **p<0.01, ***p<0.001. Data represent 
mean s.e.m. Supporting information can be found in S8 Fig. 
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precursors miRNAs (pre-miRNAs) in the nucleus and then into mature 
miRNAs in the cytoplasm (Ha and Kim, 2014).  
 
To determine whether miR-29 biogenesis is modulated by SAM68, we 
quantified the level of pre- and mature miR-29s after Sam68 knockdown. We 
found that pre-miR-29b and pre-miR-29c were significantly up-regulated in 
N2a cells (Fig. 5a). Similarly, Sam68 knockdown (S9a Fig) led to an increase 
in mature miR-29a, b and c, confirming that SAM68 is implicated in the 
biogenesis of these miRNAs (Fig. 5a). Although previous studies found that 
miR-182 and miR-10b are dynamically regulated after fear conditioning 
(Griggs et al., 2013; Kye et al., 2011) the expression of these miRNAs was 
not affected by Sam68 knockdown, showing a clear selectivity of the effect 
(S9b Fig). Since primary, precursor and mature miR-29b were up-regulated 
upon Sam68 knockdown, it indicates that SAM68 likely exerts its regulatory 
effect at the transcriptional level. 
 
To further investigate the mechanisms by which SAM68 modulates miR-29 
biogenesis, we used the transcription inhibitor actinomycin D (ActD) to test 
whether transcription is responsible for the up-regulation of precursors and 
mature forms of miR-29b. While Sam68 knockdown led to an increased level 
of pri-miR-29a/b-1 transcripts, as well as, pre-miR-29b and pre-miR-29c, ActD 
treatment blocked these changes (Fig. 5b, c). This suggests that SAM68 likely 
acts upstream of RNA Pol II-dependent transcription to regulate miR-29b. To 
determine whether the expression of Sam68 is regulated by activity, we 
quantified the level of Sam68 transcripts in hippocampal neurons after NMDA 
stimulation. Sam68 was significantly increased 5 min after neuronal activity, 
but not 1 h later (S10 Fig). Therefore, we propose that transient increase in 
Sam68 inhibits pri-miR-29a/b transcription, thereby reducing mature miR-29b 
levels thus reinforcing Tet3 transcriptional program. 
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Figure 3-5 SAM68 modulates the biogenesis of miR-29s at the 
transcriptional level. (a) Level of precursor and mature miR-29a, b and c in N2a 
cells after Sam68 knockdown. **p<0.01, ***p<0.001 determined by unpaired t test 
(b) Level of nuclear pri-miR29a/b-1 transcripts in N2a cells after Sam68 
knockdown measured by RT-qPCR in the presence of ActD treatment or vehicle. 
(c) Level of pre-miR-29a, b and c in N2a cells after Sam68 knockdown measured 
by RT-qPCR in the presence of ActD treatment or vehicle. **p<0.01, ***p<0.001 
determined by two-way ANOVA followed by Bonferroni’s post-hoc test. Data 
represent mean ± s.e.m. 
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3.5 Discussion 
 
The present data demonstrate that Tet3 expression is preferentially increased 
in the hippocampus after learning. This effect is, however, transient, as Tet3 
mRNA levels come back to baseline 24 h after training. Neuronal stimulation 
through activation of NMDA receptors in primary hippocampal neurons 
increases Tet3 mRNA levels, indicating NMDA-dependent regulation of Tet3 
expression. These results are consistent with previous data showing 
regulation of Tet3 expression upon global synaptic activity changes (Yu et al., 
2015). Thus, Tet3 activity-dependence may explain its up-regulation in the 
hippocampus after learning. Although Tet2 expression is not altered in the 
hippocampus after training, it is significantly up-regulated upon NMDA 
stimulation in primary neurons, suggesting that Tet2 is also activity-
dependent. It is possible that this up-regulation is neuron-specific, but may 
also affect glial cells. In agreement with previous reports, Tet1 transcripts 
were found to decrease in vitro (Kaas et al., 2013). Although Kaas et al. 
confirmed the effect ex vivo using the CA1 subregion of the hippocampus, we 
did not observe any significant change in the whole hippocampus in adult 
mice. Even though all TETs share the same enzymatic activity, TETs seem to 
be differentially recruited in specific sub-regions of the hippocampus upon 
learning, and thus, may contribute to different biological processes. Following 
acute stress, the level of Tet3 transcripts in the hippocampus was not 
changed, indicating that Tet3 is specifically regulated upon learning but not 
stress. 
 
The change in Tet3 expression level after CFC inversely correlates with that 
of its targeting miRNA, miR-29b. Stimulation of NMDA receptors in cultured 
hippocampal neurons also lead to alterations in miR-29 expression levels, 
indicating that changes in miR-29s, similarly to Tets, occur in an NMDA 
dependent-manner. Changes in miR-29b expression likely orchestrate a 
temporal regulation of Tet expression associated with learning by either 
releasing its mRNAs from miRNA-mediated destabilization, and/or acting as a 
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fine-tuner of gene expression by reinforcing Tet3 transcriptional program. 
Several miRNAs have been previously reported to exhibit dynamic expression 
following neuronal activity (Kye et al., 2011), suggesting that coordinated 
changes in miRNA expression contribute to the regulation of newly 
synthetized activity-dependent mRNA targets. Specifically, neuronal activity 
was found to decrease the expression of most neuronal miRNAs in the 
hippocampus (Eacker et al., 2011). This is in line with a regulatory network in 
which miRNAs maintain transcripts in a repressed state until relieved by 
neuronal activity. 
 
Threshold response in target gene expression by miRNAs has been proposed 
as a mode of gene regulation by miRNAs (Mukherji et al., 2011). Therefore, if 
the pool of Tet1, 2 and 3 mRNA is below the saturation regime of miR-29b, 
then all Tets will be similarly repressed regardless of expression level. 
However, as Tet3 mRNA level raises following neuronal activity, target de-
repression due to miR-29b saturation might occur. As Tet1 mRNA level drops 
upon neuronal activity, Tet1 is likely to be subjected to constant repression. 
Interestingly, a study reported that gene transcripts up-regulated after CFC 
have more predicted miRNA binding sites in their 3’-UTR than down-regulated 
ones (Kye et al., 2011), suggesting that down-regulated transcripts are less 
likely to be regulated by miRNAs. In agreement with this observation, Tet1 3’-
UTR has fewer putative miR-29 binding sites than Tet3 3’-UTR even if longer 
(S1 Table). 
 
Although miR-29b regulates mRNA levels of all members of the TET family 
through complementary binding to their 3’UTRs, we found that a low amount 
of miR-29b preferentially regulates Tet3 and to a lesser extent Tet2 while a 
higher amount affects all Tets. The extent of target gene repression by 
miRNAs depends on the expression level of individual miRNAs, as well as, 
their targets. In support of this idea, TET1 has low expression in the adult 
brain, while TET2 and 3 are relatively abundant, in particular in the 
hippocampus and cortex (Szwagierczak et al., 2010). Additionally, miR-29a 
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and b have a relatively broad expression pattern in the brain (Hebert et al., 
2008; Ouyang et al., 2013). The number, position, and co-operation of miRNA 
binding sites within the 3’UTR, and the secondary structures of target mRNAs 
are additional relevant factors that determine the strength of miRNA-mediated 
gene repression (Kertesz et al., 2007; Krek et al., 2005; Long et al., 2007; 
Saetrom et al., 2007). Accordingly, the predicted secondary mRNA structure 
of Tet3 contains more accessible binding sites for miR-29b than Tet1 and 
Tet2 (S2 Table), suggesting that Tet3 is more likely to be under the regulation 
of miR-29b. Consistently, Tet3 mRNA in the hippocampus was found to be 
highly enriched in the fraction of AGO2-bound mRNAs while Tet1 could not be 
detected, suggesting that in the brain Tet3 is more likely to be a target of 
miRNAs (Malmevik et al., 2015).  
 
This study demonstrates that miR-29b is important for the regulation of Tet 
expression and miR-29b itself is subjected to regulation, as its level 
decreases following learning. The biogenesis of miRNAs is extensively 
controlled by protein interactors to ensure cell/tissue specific functions or 
appropriate response to stimuli. One of the largest groups of proteins that has 
been recognized as important modulator of miRNA biogenesis and function 
are RBPs. We provided evidence that the RBP SAM68 is involved in the 
biogenesis of the miR-29 family. As Sam68 knockdown leads to increased 
expression of pri-miR-29a/b, precursor and mature miR-29b, SAM68 is likely 
to mediate its negative regulatory effect at the transcriptional level. 
Consistently, SAM68 was previously shown to play a role in transcriptional 
regulation that is independent of its RNA binding activity (Hong et al., 2002; Li 
and Richard, 2016). We further found that Sam68 expression is transiently 
regulated by neuronal activity in hippocampal neurons. Previous work has 
shown that neuronal activity triggers activation of SAM68 through 
phosphorylation at serine 20 (Iijima et al., 2011), providing evidence that 
SAM68 is controlled in an activity-dependent manner. Consequently, SAM68 
is likely to modulate miR-29b transcription upon neuronal activity, ultimately 
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leading to reduced mature miR-29 levels, thus allowing Tet3 transcripts to 
increase. 
 
Activity-dependent increase of Tet3 in the hippocampus after CFC is 
proposed to impact on the transcriptional activity of genes related to 
contextual memory formation. In line with this hypothesis, TET3 was recently 
identified as a critical regulator of activity-induced gene expression in cultured 
neurons. In this study, a high proportion of genes which expression changes 
upon neuronal activity, lost responsiveness after Tet3 knockdown (Yu et al., 
2015). Our transcriptional analyses revealed that synaptic plasticity and 
memory-related genes are sensitive to changes in TET3 levels. Among the 
transcriptional target of TET3, we identified the transcription factors CREB1 
and ELK1, as well as, the coactivator CREBBP, which are known to play a 
pivotal role in the formation of long-term memory (Alberini, 2009) via the 
regulation of immediate early genes such as C-fos. Other TET3-sensitive loci 
include genes involved in active DNA demethylation such as Gadd45a and 
Gadd45b. Similar findings were previously reported by Kaas et al., who 
identified genes encoding enzymes that act downstream of TET-mediated 5-
mC oxidation, including Tdg, Apobec1, Smug1 and Mbd4, to be sensitive to 
TET1 protein levels. Consistently, mapping of TET3 genomic binding sites in 
the embryonic mouse brain revealed TET3 selective targeting of base 
excision repair genes (Jin et al., 2016). We further demonstrate that Notch1 
and Notch2 expression levels decrease upon Tet3 knockdown. Interestingly, 
previous work has shown that NOTCH signaling is induced in neurons by 
increased activity, and conditional knockout of Notch1 in the hippocampus 
alters synaptic plasticity and memory acquisition (Alberi et al., 2011). In 
addition, many genes encoding Notch signaling components were previously 
identified to present activity-induced CpG (de)methylation and expression 
changes in response to neuronal stimulation in the dentate gyrus (Guo et al., 
2011b). TET3 may therefore contribute to the epigenetic control of genes 
involved in NOTCH signaling pathway upon neuronal activity. 
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In neuronal cells, TET3 binding was demonstrated to be targeted to genes 
involved in mRNA processing and splicing, including Sam68 (Jin et al., 2016). 
This observation raises the intriguing possibility that Sam68 is sensitive to 
TET3 levels. We indeed found that Sam68 is up-regulated upon Tet3 
knockdown, while its expression is reduced upon Tet3 overexpression in N2a 
cells (S11 a, b Fig). Based on these findings, we propose that increased TET3 
levels negatively affect Sam68 gene expression, and this regulatory loop 
allows TET3 transient expression upon neuronal activity (S12 Fig). 
 
Although specific genes implicated in learning and memory were 
demonstrated to be susceptible to TET3-mediated transcriptional regulation, 
little is known about TET3 involvement in memory processes. The only 
demonstration that TET3 may contribute to memory processes comes from a 
study by Li et al., which reported that Tet3 knockdown in the prefrontal cortex 
is associated with impaired extinction learning (Li et al., 2014b). Further 
investigations will be required to determine what are the effects of TET3 
depletion or overexpression in the hippocampus on memory performance. 
Furthermore, the effects of miR-29 depletion on 5-mC and 5-hmC profiles and 
the impact on learning and memory formation remain unknown. Importantly, 
miR-29a and b have previously been shown to affect synapse formation and 
plasticity (Lippi et al., 2011) and have been linked to neurodegenerative 
disease such as Alzheimer’s (Hebert et al., 2008). As DNA (de-)methylation is 
essential for memory formation and plasticity, disrupting the SAM68-miR-29s-
TETs regulatory circuit may interfere with physiological functions and 
contribute to the etiology of neurodegenerative disorders. 
 
 
3.1 Methods 
 
Animals. C57Bl/6J mice were maintained under a reverse light-dark cycle in 
a temperature and humidity-controlled facility with food and water ad libitum. 
All experimental manipulations were performed during the animals' active 
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cycle in accordance with guidelines and regulations of the cantonal veterinary 
office, Zurich. All behavioral tests were conducted in adult male animals by 
experimenters blind to treatment. 
 
Contextual fear conditioning. Mice were handled for three days prior to 
training and testing. Mice were then trained in a contextual fear conditioning 
(CFC) paradigm (TSE). They were placed in the chamber (context) for 2 mins 
before receiving three brief electric foot-shocks 1 min apart (0.3 mA for 1s) 
followed by another 2 min in the chamber. Fear conditioned animals were 
euthanized 30 min, 3 hours, 24 hours after conditioning. Control animals were 
exposed to the same chamber for the same duration but received no foot 
shock and were sacrificed 30 min later. Mice were tested 24 hours after 
training by re-exposure to the context in the absence of foot-shock. Freezing 
response was measured for 2 min immediately before and 24h after fear 
conditioning and was reported as a percentage of time. 
 
Forced swim test. Mice were placed in a small tank of water (18 cm high, 13 
cm diameter, 18 ± 1 °C, filled up to 12 cm) for 6 min. Floating duration was 
scored manually. 
 
Brain tissue collection and processing. Immediately after sacrifice, the 
brain was removed and the hippocampus rapidly dissected on ice and stored 
at −80 °C. To avoid potential hemispheric lateralization, both hippocampi were 
pooled and cryohomogenized as previously described (von Ziegler et al., 
2013). 
 
Cell culture. Mouse neuroblastoma (N2a) cells (from ATCC) were cultured in 
Dulbecco's modified eagle medium (DMEM-high glucose) supplemented with 
10% (v/v) fetal bovine serum (Gibco®) and 1% Antibiotic-Antimycotic (Gibco 
®). Cells were treated with 40 nM miScript miRNA mimic or inhibitor (Qiagen) 
and a negative control siRNA with no known target in mammalian genome (All 
Stars Negative siRNA, Qiagen). Transfections were carried out using lipid-
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based HiPerfect transfection reagent (Qiagen). Cells were harvested 24 h 
after transfection by removing the medium, washing with PBS, and total RNA 
was isolated using standardized Trizol protocol. Transfection with a pool of 
siRNAs directed against Tet3 or Khdrbs1 (Flexitube Gene Solution, Qiagen) 
and negative control siRNA (All Stars Negative siRNA, Qiagen) was carried 
out with Lipofectamine® 2000 transfection reagent (ThermoFischer Scientific) 
according to the manufacturer's recommendations. In actinomycin D (Tocris®) 
treatment conditions, the cells were treated with 2.5 µg/ml of the drug 
prepared in DMSO for 2 h before harvest. Overexpression of Tet3 were 
performed using Purefection reagent (System Bioscience) according to the 
manufacturer's recommendations. Plasmid pEF-DEST51 containing Tet3 
ORF with the CxxC DNA-binding domain was a kind gift from Prof Gerd 
Pfeifer. 
 
Primary neuronal culture. Neuronal hippocampal cultures were prepared 
from E-18 embryos and grown in Neurobasal medium supplemented with 
B27, 1 µg/µl gentamycin, 2 mM glutamax. NMDA stimulation was induced by 
incubating neurons (11 DIV) for 5 min with 50 µM NMDA, after which neurons 
were returned to fresh medium. Glycine stimulation was induced in 11 DIV 
hippocampal cultures as previously described (Raynaud et al., 2013). Briefly, 
activation of NMDA receptors was achieved by incubating neurons for 3 min 
with saturating levels (200 μM) of the co-agonist glycine, in Mg2+-free 
extracellular medium. Neurons were harvested 5 min or 1 h after stimulation in 
Trizol® reagent (Invitrogen). 
 
miRNA targets prediction. TargetScan6.2 (Lewis et al., 2005), which is 
based on potential binding site in the 3′ untranslated region of the mRNA and 
predicted stable thermodynamic binding, was used to predict miRNAs that 
target Tets. Secondary structures of miR-29s binding sites to Tet3 3’-UTR and 
mimimum free energy were predicted according to RNAfold (Lorenz et al., 
2011) or STarMir (Ding et al., 2004). 
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RNA extraction and real-time quantitative reverse transcription-PCR (RT-
qPCR). Mouse hippocampal tissue was homogenized using TissueLyser 
(Qiagen) in Trizol® reagent (Invitrogen). Total RNA was isolated according to 
the manufacturer's recommendations. Subcellular fractionation of nuclear and 
cytoplasmic RNA was performed using Norgen’s Cytoplasmic and nuclear 
RNA purification kit (Norgen BioTek Corp). Nuclear RNA was further treated 
with RNase-free DNase I kit (Norgen BioTek Corp) to remove genomic DNA 
contaminations. For mRNAs, total RNA was reverse-transcribed using M-MLV 
reverse transcriptase (Promega). RT-qPCR were performed using SYBR 
Green (Roche) on a Light-Cycler II 480 (Roche) according to the 
manufacturer's recommendations. Custom designed gene specific primers 
were used (S3 Table). Data for brain samples were normalized to two 
endogenous controls Gapdh and Actb, and data for cellular samples were 
normalized to Tubd1 and Hprt1. Cycling conditions: 5 min at 95 °C, 45 cycles 
with denaturation (10 s at 95 °C), annealing (10 s at 60 °C) and elongation (8-
10 s at 72 °C). For miRNAs, total RNA was reverse-transcribed using miScript 
II reverse transcription kit® (Qiagen). Miscript primer assays for mature and 
precursor miRNAs (Qiagen) were used to amplify the respective transcripts 
from a cDNA pool. RT-qPCR was performed in a LightCycler 480 qPCR 
(Roche) according to the manufacturer's recommendations. Ribosomal Rnu6 
and Snord61 were used for normalization of Ct values for miRNAs. The primer 
sequences used for the quantification of mRNAs and miRNAs are shown in 
Table S3. 
 
Luciferase reporter assays. For validation of Tet1, 2, 3 and Dnmt3a 
targeting by miR-29b, segments of their 3’UTR including miR-29b seed 
sequences were amplified from mouse genomic DNA and cloned into 
pmirGLO Dual-Luciferase miRNA target expression vector (Promega). N2a 
cells were co-transfected with miR-29b mimics or negative control (All Stars 
Negative siRNA, Qiagen) and 250 ng of pmirGLO with Lipofectamine® 2000 
(Life Technologies) for 24h. Cell extracts were prepared 24h post-transfection, 
and luciferase activities of firefly and renilla were measured using a Dual-
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Luciferase Reporter Assay system (Promega) and with a luminometer GloMax 
96 (Promega). Firefly luciferase signals were normalized to Renilla luciferase 
signals, which serves as internal normalization control. Values were further 
normalized by that of an empty pmirGLO vector. The primer sequences used 
for cloning are shown in Table S4. 
 
Statistical Analysis. Statistical comparisons between two groups were 
performed using an unpaired Student t-test. One or two-way ANOVA were 
performed followed by Dunnett’s and Bonferroni’s posthoc analyses when 
appropriate. All analyzed data matched the requirements for parametric 
statistical tests (normal distribution). If variance was not homogenous 
between groups (determined by Browth-Forsythe’s test), 
adjusted P value, t value and degree of freedom were determined (Welch 
correction). Values over two standard deviations away from the mean of each 
group were considered outliers and excluded from analysis. All statistics were 
computed with Graphpad Prism. All reported replicates were biological 
replicates. Significance was set at P < 0.05 for all tests. Error bars represent 
s.e.m. in all figures. 
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Figure 3-S1 Contextual fear conditioning paradigm. (a) During habituation, 
a mouse was familiarized to an environment different from the home cage 
(context 1, 2 and 3) and was then placed in a novel context, where it receives 3 
electric footshocks. After 24h, the animal was placed back in the context 
without any shock. The freezing response was measured as an indicator of fear 
memory. (b) Left bar shows baseline freezing before delivery of the foot shock, 
right bar shows freezing during context test (24h after conditioning). ***p<0.001. 
Data represent mean s.e.m. 
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Figure 3-S 2 Tet3 is not responsive to stress. (a) Mice were placed in a small 
tank of water filled with cold water for 6 min and sacrificed 15, 30, 90, 120 min 
later (left panel). Level of hippocampal C-fos transcripts after subjection to cold 
swim measured by RT-qPCR. (b) Level of hippocampal Tet1, 2 and 3 transcripts 
after subjection to cold swim measured by RT-qPCR. Data represent mean s.e.m.  
	  	   	   88	  
 
  
c-fos
Ve
hic
le
NM
DA
0
10
20
30
40
50
m
R
N
A 
ex
pr
es
si
on
 
(fo
ld
 c
ha
ng
e)
***
a
c
S3 Fig
5 m
in 1 h
0.0
0.5
1.0
1.5
2.0
m
R
N
A 
ex
pr
es
si
on
(fo
ld
 c
ha
ng
e)
Tet1
5 m
in 1 h
0.0
0.5
1.0
1.5
2.0
Tet2
* *
5 m
in 1 h
0.0
0.5
1.0
1.5
2.0
Tet3*
* Vehicle
Glycine
c-fos
Ve
hic
le
Gl
yc
ine
0
2
4
6
8
10
m
R
N
A 
ex
pr
es
si
on
 
(fo
ld
 c
ha
ng
e) **
b
Figure 3-S3 Tet3 is responsive to activation of NMDA receptors with 
glycine. (a) Level of C-fos in hippocampal primary neurons 1h after NMDA 
stimulation measured by RT-qPCR. (b) Level of C-fos in hippocampal primary 
neurons 1h after glycine stimulation measured by RT-qPCR. (c) Level of Tet1, 
2, and 3 in hippocampal primary neurons 5 min and 1h after glycine stimulation 
measured by RT-qPCR. *p<0.05. Data represent mean s.e.m. 
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Figure 3-S4 Activation of NMDA receptors with glycine leads to 
decreased miR-29b expression. Level of miR-29 a, b, and c in hippocampal 
primary neurons 5 min and 1h after glycine stimulation measured by RT-qPCR. 
*p<0.05. Data represent mean s.e.m.  
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Figure 3-S5 MiR-29b binds to Tet1 and Tet2 3’ UTRs and control their 
expression. (a) Segments of Tet1, Tet2 and Tet3 3’UTRs were cloned into a 
luciferase reporter; each segment contains conserved seed sequences (indicated 
in red) for the miR-29 family as predicted by TargetScan [1] (S1 Table). (b) 
Analysis of Tet1 and Tet2 luciferase reporters in the presence of miR-29b mimic 
or control (40 nM) in N2a cells. *p<0.05, **p<0.01, ***p<0.001. Data represent 
mean s.e.m 
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Figure 3-S6 Luciferase activity of empty vector is stable in the presence of 
miR-29b or control. Analysis of the luciferase activity in N2a cells transfected with 
empty vector in the presence of graded concentrations of miR-29b mimic or 
control. Data represent mean s.e.m.  
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Figure 3-S7 MiR-29b targets Dnmt3a and –b. (a) Level of Dnmt3a, -b and 1 in 
N2a cells 24h after transfection with 29b mimic or control measured by RT-
qPCR. (b) Analysis of Dnmt3a luciferase reporter in the presence of miR-29b 
mimic or control (40 nM) in N2a cells. *p<0.05, **p<0.01. Data represent mean 
s.e.m. 
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Figure 3-S8 Knockdown of Tet3 specifically reduces Tet3 mRNA level. Level 
of Tet1, Tet2, and Tet3 in N2a cells after transfection with a pool of siRNAs directed 
against Tet3 or control measured by RT-qPCR. ***p<0.001. Data represent mean 
s.e.m.  
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Figure 3-S9 Knockdown of Sam68 does not alter precursor and mature 
miR-182 and miR-10b expression level. (a) Level of Sam68 in N2a cells after 
transfection with a pool of siRNAs directed against Sam68 or control measured 
by RT-qPCR. (b) Level of precursor and mature miR-182 and miR-10b after 
transfection with a pool of siRNAs directed to Sam68 or control measured by 
RT-qPCR. ***p<0.001. Data represent mean s.e.m. 
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Figure 3-S10 SAM68 modulates the biogenesis of miR-29s at the 
transcriptional level. Level of pre-miR-29a, b and c in N2a cells after Sam68 
knockdown measured by RT-qPCR in the presence of ActD treatment or vehicle. 
**p<0.01, ***p<0.001. Data represent mean s.e.m.  
Figure 3-S11 Sam68 expression is sensitive to TET3 levels. (a) Level of 
Sam68 in N2a cells after transfection with a pool of siRNAs directed against 
Tet3 or control measured by RT-qPCR. (b) Level of Sam68 in N2a cells after 
transfection with a plasmid overexpressing Tet3 containg the CxxC DNA-
binding domain or empty vector measured by RT-qPCR. *p<0.05, **p<0.01. 
Data represent mean s.e.m. 
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S12 Fig
Figure 3-S12 Model for the regulation of Tet3 via miR-29b and SAM68. 
Upon neuronal activity, SAM68 inhibits miR-29b transcription, leading to 
reduced mature miR-29 levels, thus allowing Tet3 transcripts to increase. 
TET3 likely inhibits Sam68 expression by binding to its promoter, thus 
allowing transient Tet3 expression in response to neuronal activity. 
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 !
Site position Seed position Seed type PCT
42-57 51-57 7mer-m8 0.83
1032-1039 1032-1038 7mer-m8 0.82
1358-1373 1367-1373 7mer-m8 0.73
3680-3706 3699-3705 8mer 0.89
3721-3753 3747-3752 7mer-1A 0.87
3807-3831 3824-3830 7mer-m8 0.73
4248-4265 4258-4264 8mer 0.85
297-322 316-322 7mer-m8 0.68
407-423 417-423 7mer-m8 0.89
1326-1359 1353-1358 7mer-A1 0.7
1399-1430 1424-1430 7mer-m8 0.89
367-405 398-404 7mer-m8 0.68
525-564 557-563 8mer 0.89
1032-1061 1055-1061 7mer-m8 0.7
1587-1621 1614-1620 8mer 0.89
Tet1 3'UTR
Tet2 3'UTR
Tet3 3'UTR
Table S1 Modified output table of TargetScanMouse analysis.List of 
complementary sites for miR-29s in the 3’UTR region of Tet1, 2 and 3 predicted by 
TargetScanMouse (Lewis et al., 2005). Tet3 3’UTR contains seven well-conserved 
miR-29s binding sites, while Tet1 and Tet2 has four only. The site position 
represents the distance (bp) between the stop codon and binding sites of miR-29b. 
The seed position represents the distance (bp) between the stop codon and 
binding sites of the seed sequence of miR-29b. PCT is defined as the probability of 
conserved targeting. 
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S2 Table  
 
!!
Site position Seed position ΔGhybrid Site Access Seed Access
42-57 51-57 -22 0.35 0.447
963-994 989-994 -18.8 0.365 0.333
982-1005 1000-1005 -19.5 0.33 0.202
1010-1016 1010-1015 -16.7 0.294 0.325
1013-1026 1019-1025 -22.6 0.262 0.17
1032-1039 1032-1038 -17.5 0.198 0.225
1148-1164 1159-1164 -21.3 0.477 0.291
1310-1336 1331-1336 -18.8 0.476 0.314
1358-1373 1367-1373 -18.4 0.391 0.386
3062-3082 3077-3082 -21.4 0.455 0.447
3327-3338 3332-3337 -16.5 0.481 0.291
3680-3706 3699-3705 -22.9 0.509 0.344
3721-3753 3747-3752 -20.5 0.58 0.365
3807-3831 3824-3830 -19.7 0.301 0.286
4069-4086 4080-4085 -19.3 0.447 0.47
4178-4201 4195-4201 -20.6 0.452 0.432
4205-4220 4215-4220 -15.6 0.311 0.406
4248-4265 4258-4264 -23.1 0.278 0.357
6454-6490 6483-6489 -25.7 0.346 0.458
407-423 417-423 -20.4 0.306 0.409
79-96 90-95 -18.3 0.372 0.241
2043-2082 2076-2082 -19.1 0.338 0.253
297-322 316-322 -18.1 0.453 0.555
1326-1359 1353-1358 -21.5 0.304 0.49
1521-1537 1532-1537 -19 0.44 0.178
1399-1430 1424-1430 -21.7 0.412 0.854
5250-5275 5269-5275 -22.5 0.464 0.446
6987-7004 6999-7004 -20.6 0.316 0.18
4551-4581 4574-4580 -24.5 0.241 0.041
457-474 469-474 -20.5 0.193 0.204
7651-7665 7660-7665 -16.2 0.154 0.032
1455-1476 1471-1476 -17.9 0.305 0.144
1587-1621 1614-1620 -23.3 0.375 0.13
525-564 557-563 -28.6 0.417 0.463
1032-1061 1055-1061 -19 0.465 0.456
367-405 398-404 -25 0.203 0.268
1129-1168 1161-1167 -20.8 0.333 0.07
Tet3 3'UTR
Tet1 3'UTR
Tet2 3'UTR
mmu-miR-29b-3p
Table S2 Modified output table of STarMiR analysis. Free energy in kcal/mol 
(ΔGhybrid) analysis of putative miR-29b binding site to each Tet 3’UTR, and 
measure of the structural accessibility in the predicted binding site (Site Access) or 
in the target sub-region complementary to the miRNA seed (Seed Access) as 
defined by STarMir (Ding et al., 2004). Highlighted rows are conserved miR-29b 
binding sites as predicted by TargetScanMouse (Lewis et al., 2005) (S1 Table). 
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S3 Table  
 
 !
Genes Forward primer (5’->3’) Reverse primer (5’->3’)
Tubd1 TCTCTTGCTAACTTGGTGGTCCTC GCTGGGTCTTTAAATCCCTCTACG
Hprt1 GTTGGGCTTACCTCACTGCTTTC CCTGGTTCATCATCGCTAATCACG
Actb CAACGGCTCCGGCATGTGC CTCTTGCTCTGGGCCTCG
Gapdh CAGCAATGCATCCTGCACC TGGACTGTGGTCATGAGCCC
Tet1 TTGCTGGAGACTGTCGACTTGG TGCTCGAATCAACGTACACACCAC
Tet2 TGCCAAATGGCAGTACAGTGGTG ATCCTCAGGCTTAGCTCCGACTTC
Tet3 GCATCGGGCAGGCCACCATT GGCAAGCACAGGTCCGGTCA
Dnmt3a CAGCTGCTTACGCCCCACCC CACCAGCCGCTCCCTTGTGC
Dnmt3b AAAGCCCGGCTGTCCGAACC CCCTGCCGACCTCGGGTGAT
Dnmt1 AGTCTGTTCCTGTGCAGAAGGC TGCTGAAGAAGCCATCCCACTC
Fos ACAGATACACTCCAAGCGGAGAC TGGCAATCTCAGTCTGCAACGC
Drosha CATCACGAAGGACACTTGACGTTG TGCTACCTTGGCTTGCGTTCTG
Dgcr8 GTCACTTGGTCCAGACCCTACTTC GCTTAGAGGAGGATCATGTTTCCG
Dicer TCTTCGAG CTCCATTGTTGGTC CTACCACTCTTTCACCAACCG
Ddx5 ACCATTGACGCCATGTCGAG CAAATCGAGGTGCACCAAACCC
Ddx17 AGGGATATGGTTGGCATTGCACAG CAATCGCAGGCAGCAAATACGC
p53 CACGTACTCTCCTCCCCTCAAT AACTGCACAGGGCACGTCTT
Notch 1 ACAGTGCAACCCCCTGTATG TCTAGGCCATCCCACTCACA
Notch 2 ACAGTGTTGGCTCCCTGTTC ATCGTTTACCTTGCCAGCCA
Khdrbs1 TTATGGCCCATGCTATGGAAGA AGGTACTCCGTTCAAGTAGGAC
Elk1 CTGCTCCCCACACATACCTT GAGAGGCCATCCACACTGAT
Elk4 ATCTAACAATGGGGAGTTCAAGC GGCTCGGCTGAGTTTATCATAAT
Gadd45a TGC GAG AAC GAC ATC AAC AT TCC CGG CAA AAA CAA ATA AG
Gadd45b CTGCCTCCTGGTCACGAA TTGCCTCTGCTCTCTTCACA
Tdg TAGGAAACGTGCGTGTTCAG CTCATACTGCCAAACCAGCA 
Crebbp TGGAGTGAACCCCCAGTTAG TTGCTTGCTCTCGTCTCTGA
Creb1 AGCTGCCACTCAGCCGGGTA TCGCCTGAGGCAGCTTGAACA
miRNAs
miR-29b-1
miR-29a
miR-29c
miR-10b
miR-182
Snord61_11
Rnu6
Pre-miR-29b-1
Pre-miR-29a
Pre-miR-29c
Pre-miR-10b
Pre-miR-182
Pri-miR-29a/b-1 AACTATTGCACGGACTTCACCT TCCTGA AGA AGCTTTGTCGTC
Qiagen, cat. No.: MP00004431
Qiagen, cat. No.: MS00033740
Qiagen, cat. No.: MP00005355
Qiagen, cat. No.: MP00005348
Qiagen, cat. No.: MP00005369
Qiagen, cat. No.: MP00003983
Qiagen, cat. No.:MS00033705
Source
Qiagen, cat. No.: MS00005936
Qiagen, cat. No.: MS00001372
Qiagen, cat. No.: MS00001379
Qiagen, cat. No.: MS00032249
Qiagen, cat. No.: MS00011291
Table S3 List or primers used for the quantification of mRNA and miRNA 
transcripts. 
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S4 Table 
Name Forward primer (5’->3’) Reverse primer (5’->3’)
Tet1 (1) AATGCCTTTGCTAATGTGGTG TTAGCGAACAGCTTCCAACC
Tet1 (2) AGGAAAATGGGAACCCAAAC TGAGGGAGGATTTCTGATGG
Tet2 (1) AATGCCTTTGCTAATGTGGTG TTAGCGAACAGCTTCCAACC
Tet2 (2) TCGGCTGATGAGCAGTATCA AGCAATCTGGGTAGCACCAT
Tet3 (1) TTTAAAGAAACAGTAGTTTGCAGAGC TATCATACCCTCATGGAATCTAAGTT
Tet3 (2) GCTCTTCTCGTCCCGTTGAT TAGAGCCACGTGCTAACTGC
Dnmt3a TTGGCCTTGCAAAAGGGTTG TTGCACGCGAGTCTGGATAA
Table S4 List or primers used for cloning 
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4 Discussion and outlook 	  	  
The exciting discovery of TET proteins provided a mechanism by which DNA 
demethylation may occur as they contribute to the removal of 5-
methylcytosine (5mC) by converting it to 5-hydroxymethylcytosine (5hmC). 
Given that 5hmC and TETs are abundant in the central nervous system, much 
effort has been made to understand their roles in neuronal function. 
 
While preparing the manuscript presented in Chapter 3, two major studies 
reported that TET3 in the brain functions as an important regulator of neuronal 
activity and memory. Yu and colleagues confirmed that Tet3, but not Tet1 and 
Tet2, is regulated at the mRNA level by neuronal activity in cultured 
hippocampal neurons. They further identified TET3 as an important player in 
the maintenance of homeostatic synaptic plasticity. At the molecular level, 
TET3 appears to elicit these effects through the regulation of the surface level 
of the AMPA receptor subunit GluR1 (Yu et al., 2015). These findings 
provided additional evidence that neuronal activity can modulate TET3 
expression and function in vitro. 
 
Similarly, Li et al. demonstrated that Tet3 expression is up-regulated in 
cultured cortical neurons in response to neuronal depolarization using 
potassium chloride. In their study, extinction training led to an increase in Tet3 
mRNA in the infralimbic prefrontal cortex (IlPFC), a brain region essential for 
fear memory extinction (Li et al., 2014b).  
 
The present study is complementary and builds upon these two studies. We 
provide evidence that Tet3 is regulated by learning in the hippocampus, a 
region related to cognitive processes in the brain. Furthermore, we extend 
their findings by investigating the up-stream mechanism controlling Tet3 
expression. 
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4.1 TET3 expression is activity-dependent 
 
Evidence from our study, as well as, the above-mentioned independent 
analyses establish that Tet3 expression is regulated by neuronal activity in 
vitro and in vivo. Treatment with tetrodotoxin, a sodium channel blocker and 
inhibitor of synaptic activity, or bicuculline, a GABAA receptor antagonist and 
promoter of synaptic activity, decreases and increases Tet3 expression, 
respectively (Yu et al., 2015). These findings demonstrate that Tet3 is 
modulated bi-directionally. They also confirm the effect at the protein level but 
only after 4 h of continuous pharmacological treatment. In our case, brief 
application of NMDA, an agonist of NMDA receptors that mimics the action of 
the neurotransmitter glutamate, was sufficient to trigger a rise in Tet3 
transcripts in hippocampal neurons. Further, Li et al. observed that 
pharmacological inhibition of NMDA receptors activity in vivo blocks the 
increase in Tet3 expression in the IlPFC associated with fear memory 
extinction (Li et al., 2014b). These findings collectively suggest that neuronal 
activity induces an increase in Tet3 level via an NMDA receptor-dependent 
signaling pathway. 
 
The observation that Tet1 is unaltered in the hippocampus upon contextual 
fear conditioning (CFC) appears, at first glance, intriguing as an earlier report 
by Kaas et al. showed that Tet1 but not Tet3 is regulated by activity (Kaas et 
al., 2013). In this study, however, TET enzymes were specifically quantified in 
the CA1 area of the dorsal hippocampus, a hippocampal subregion that has 
been associated with retrieval of contextual memories (Daumas et al., 2005; 
Lee and Kesner, 2004). As the hippocampus is composed of multiple 
subregions, including CA2, CA3 and dentate gyrus, TET3 could be 
differentially modulated by neuronal activity in different hippocampal regions. 
 
Similarly, behavioral experiences were reported to alter the expression of 
other components of the DNA (de)methylation machinery, such as Dnmt3a 
(Miller and Sweatt, 2007), Dnmt3a2 (Oliveira et al., 2012), and Gadd45b 
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(Sultan et al., 2012). In particular, the expression of Dnmt3a2 in the 
hippocampus is robustly and transiently enhanced by neuronal activity in vitro 
and by learning in vivo, and this modulation depends on the activation of 
NMDA receptors. Interestingly, these changes occur during the initial 
consolidation window (shortly post-training, within 3 h) in the hippocampus in 
response to training. This indicates that they are important for memory 
acquisition, rather than for the persistence of memory over time.  
 
We observed that Tet3 expression goes back to baseline level 24 h after 
training; a time-point at which a second wave of hippocampal gene 
expression occurs that is required for the persistence of long-term memory 
(LTM) (Katche et al., 2010). Consistently, Miller and Sweatt have reported a 
similar temporal pattern of DNMT gene expression and DNA methylation in 
the hippocampus following CFC. Accordingly, locus-specific DNA methylation 
occurred 1 h after training but these changes in DNA methylation returned to 
baseline within 24 h (Miller and Sweatt, 2007). Other epigenetic processes, 
such as histone acetylation, histone methylation, and histone phosphorylation 
exhibit similar temporal regulation pattern in the hippocampus after fear 
conditioning (Chwang et al., 2006; Gupta-agarwal et al., 2012; Gupta et al., 
2010; Levenson et al., 2004). 
 
Our results further indicate a non-significant increase in hippocampal Tet3 
transcripts on memory reactivation (memory retrieval). In line with this finding, 
a recent study revealed an increase in global 5hmC levels in the CA1 region 
of the hippocampus in rats, as well as, Tet3 mRNA and protein levels 1 h after 
the reactivation of fear memory (Webb et al., 2017). To date, very little is 
known about the extent to which epigenetic mechanisms contribute to 
memory retrieval and further studies are required to elucidate these 
mechanisms. In summary, epigenetic modifiers, including TETs, seem to 
occur in waves in the hippocampus, thus they may contribute to the temporal 
regulation of the gene expression profile that is critical for memory. 
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Although Tet3 gene expression was induced by activity in the hippocampus 
and in cultured neurons, we could not confirm the effect at the protein level. 
Unfortunately, commercially available anti-TET3 antibodies are highly 
unreliable. In addition, at least three different TET3 isoforms are known to 
exist: an isoform containing an N-terminal CXXC domain, one isoform lacking 
the CXXC domain, and finally one isoform that is oocyte-specific (Jin et al., 
2016). Neuronal activity may enhance the expression of distinct isoforms that 
are not detectable with commercially available antibodies.  
 
Another possibility is that TET3 protein may have a very high turnover rate in 
neurons, making it difficult to detect. Interestingly, a recent study provided 
evidence that TET proteins are direct substrates of calpains, a group of 
calcium-dependent proteases (Wang and Zhang, 2014). As neuronal activity 
triggers calcium-signaling cascades in neurons, studying how calpain-
mediated TET degradation in the context of neuronal activity could be 
pertinent. 
 
Although TET3 expression is dynamically regulated in the hippocampus upon 
fear memory acquisition and retrieval, as well as, in the prefrontal cortex after 
memory extinction, little is known about the function of TET3 in these 
processes. The strongest evidence was provided by Li and colleagues, who 
showed that lentiviral-induced TET3 reduction in the prefrontal cortex is 
sufficient to impair fear memory extinction (Li et al., 2014b). Further research 
will be required to determine what are the effects of TET3 depletion or 
overexpression in the hippocampus on memory performance. As deletion of 
Tet3 leads to neonatal lethality (Gu et al., 2011), conditional brain specific 
Tet3 knockout models would be most suitable for such analysis. A further 
consideration while designing these studies would be to account for the 
redundancy and compensatory functions between different TET enzymes 
(Dawlaty et al., 2013). 
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4.2 TET3 acts as a regulator of gene expression 
 
We postulated that activity-dependent Tet3 up-regulation in the hippocampus 
upon CFC affects the transcriptional activity of genes related to the formation 
of contextual memories, likely by modulating the 5mC and 5hmC landscape of 
its target. The idea that TET3 plays a role in transcriptional regulation is also 
supported by the observation that TET3 interacts with transcriptional 
regulators and histone writers such as the RE1-silencing transcription factor 
(REST) and histone-lysine N-methyltransferase (NSD3) in neurons (Perera et 
al., 2015). 
 
Using siRNA-mediated Tet3 knockdown in vitro, we identified altered 
expression of genes coding for transcription factors and their coactivators, 
such as Creb1, Elk1 and Crebbp, which are crucial for the formation of 
memory (Alberini, 2009). Furthermore, expression level of genes coding for 
effectors of the active DNA demethylation pathway, including Gadd45a and 
Gadd45b is altered upon Tet3 knockdown conditions. Importantly, neuronal 
activity has been shown to alter Gadd45b expression, which mediates gene-
specific demethylation of Bdnf, a gene coding for a growth factor important for 
neurogenesis, synaptic plasticity, and learning and memory (Ma et al., 2009; 
Sultan et al., 2012). TET3 may therefore be implicated in the regulation of 
Gadd45b in the context of neuronal activity.  
 
Lastly, we showed that Notch1 and Notch2 are sensitive to Tet3 levels. Notch 
signaling components, including Notch 1 and Notch 2, have been previously 
associated with activity-induced CpG (de)methylation and expression 
changes in response to neuronal stimulation in the rodent dentate gyrus (Guo 
et al., 2011b), which points towards a role of TET3 in the activity-dependent 
regulation of Notch genes in the context of neuronal activity, However, further 
experiments validating these in vitro findings in the brain are needed. 
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Meanwhile, other studies have employed high-throughput approaches in order 
to examine the impact of TET3 manipulation on transcription regulation and its 
effect on neuronal morphology and physiology. Specifically, overexpression of 
TET3 in mouse olfactory sensory neurons (mOSN) altered 5hmC patterns and 
expression of mOSN-specific genes (Colquitt et al., 2013). In addition, 
lentiviral-mediated TET3 overexpression in retinal explant cultures resulted in 
the up-regulation of 981 proteins, mainly related to neuronal functions (Perera 
et al., 2015). NOTCH1 and 2 were listed among the 981 up-regulated proteins 
by TET3 overexpression, confirming our earlier observation. Overall, these 
findings are indicative of a role for TET3 in regulating gene expression in the 
brain. 
 
To dissect the role of TET3 in synaptic activity-dependent gene expression, 
Yu and coworkers assessed global gene expression changes in Tet3 
knockdown neurons in the presence and absence of neuronal activity. Tet3 
knockdown resulted in the differential expression of 2873 genes, mainly 
genes involved in synaptic transmission.	   Interestingly, 85% of the activity-
dependent genes that exhibited differential expression in response to 
neuronal activity lost responsiveness in Tet3 knockdown neurons (Yu et al., 
2015). This means that TET3 is an essential regulator of activity-dependent 
gene transcription in neurons. In vivo studies are required to validate these 
findings in the brain. 
 
Finally, for confirmation of TET3 targets, chromatin-immunoprecipitation is an 
ideal approach. This technique, however, has been difficult to implement 
owing to the lack of chromatin immunoprecipitation (ChIP)-grade TET3 
antibodies. To circumvent this problem, Yu and colleagues took advantage of 
a FLAG-tagged TET3, and demonstrated a direct binding TET3 to Bdnf 
promoter region in hippocampal neurons (Yu et al., 2015). This is of particular 
interest as Bdnf promoter is susceptible to demethylation after neuronal 
stimulation (Ma et al., 2009).  
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Very recently, endogenous TET3 was mapped across the whole genome in 
mouse embryonic brain (E15.5) using a homemade antibody specifically 
targeting TET3 DNA-binding domain CXXC. Although restricted to one 
specific TET3 isoform, this is the first study that provides information about 
TET3 genomic localization in the brain. TET3 appears to be targeted near 
transcription start sites of genes involved in lysosome function, mRNA 
processing, splicing, and base excision repair (Jin et al., 2016). The 
association of TET3 at genes functioning in base excision repair is intriguing. 
TET proteins seem to share redundant functions as manipulation of TET1 in 
the brain affects the expression of genes related to TET-mediated 5mC 
oxidation such as Tdg, Apobec1, Smug1 and Mbd4 (Kaas et al., 2013). 
Furthermore, it was reported that TET1 interacts with TDG and stabilizes its 
activity, providing strong evidence for a coupling of 5mC oxidation and TDG-
initiated base excision repair (Weber et al., 2016). 
 
 
4.3 MicroRNA-29s, a family of epi-miRNAs 
 
MiRNAs are critical regulators of gene expression in the brain, performing 
post-transcriptional regulation of gene expression in a rapid and site-specific 
manner in response to neuronal activity (Sim et al., 2014). We demonstrate 
that miR-29b binds to the three prime untranslated region (3’UTR) of all Tets 
and regulates their expression. Importantly, even low amounts of miR-29b can 
regulate Tet3 and to a lesser extent Tet2, while a higher amount affects all 
Tets. Consistently, other studies reported that the three members of the miR-
29 cluster target the 3’UTR of Tet1 in human cancer cell lines (Morita et al., 
2013; Zhang et al., 2013a). Interestingly, they can also modulate Tdg 
transcript levels, indicative of a general role for this miR cluster in the 
regulation of components of the DNA demethylation machinery (Morita et al., 
2013).  
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Tet 3’UTRs contain predicted binding sites for other miRNAs, many of which 
are altered by neuronal activity and learning, including miR-140 and miR-291 
(Kye et al., 2011). However, 3’UTR of Tets has the highest number of 
predicted binding sites for 29s according to in silico analyses provided by 
Targetscan, which suggests that Tet transcripts are likely to be more sensitive 
to miR-29s as compared to any other miRNAs. Indeed, we observed that the 
expression of the miR-29 cluster is altered upon neuronal activity in vitro and 
by learning in vivo, in a manner opposite to Tet3. 
 
Independent analyses have previously suggested a sensitivity of miR-29 
family to neuronal activity and its potential role in learning and memory. Kye et 
al. examined the expression profile of selected miRNAs upon CFC in the 
hippocampal CA1 region. Among many other miRNAs, miR-29b expression 
level was significantly decreased 1 h after training, consistent with our results 
(Kye et al., 2011). Furthermore, high-throughput profiling of miRNA 
expression in the hippocampus in response to neuronal activity revealed that 
only a subset of miRNAs is induced by activity while nearly all miRNAs 
decline in expression (Eacker et al., 2011) Therefore, a decline in the level of 
mature miRNAs, such as for miR-29b, likely contributes in establishing a 
permissive landscape for de novo protein synthesis. In particular, if 
simultaneously the miRNA target’s abundance rises enough to titrate the 
miRNA, then all targets of that miRNA should be derepressed as suggested 
previously (Mukherji et al., 2011). Therefore, if the pool of Tet1, 2 and 3 
mRNA is below the saturation regime of miR-29b, then all Tets will be similarly 
repressed regardless of expression level. However, as Tet3 mRNA level 
raises following neuronal activity, target de-repression due to miR-29b 
saturation might occur. It remains to be determined, however, whether miR-
29b decline is essential for Tet3 activity-dependent up-regulation after 
neuronal activity.  
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4.1 SAM68 regulates miR-29 biogenesis 
 
MiRNA biogenesis is a tightly regulated process, with complex mechanisms 
controlling the transcriptional production of pri-miRNAs, as well as, their 
subsequent processing by the microprocessor complex and DICER (Loffreda 
et al., 2015). Importantly, some RNA-binding proteins (RBPs) have been 
implicated in these regulatory processes. We found that the RBP SAM68 (Src-
associated in mitosis 68 kDa protein), also known as KHDRBS1 (KH domain 
containing, RNA binding, signal transduction associated 1) is involved in the 
biogenesis of the miR-29 cluster.  
 
SAM68 belongs to the STAR (signal transduction activator of RNA 
metabolism) family of RBPs, which regulates various aspects of RNA 
metabolism in response to signaling cascades, including transcription, pre-
mRNA splicing and RNA transport. SAM68 regulates splicing during cell 
differentiation, namely upon spermatogenesis, adipogenesis, and 
neurogenesis (Paronetto et al., 2011; Vogel and Richard, 2012). In addition, 
SAM68 regulates the activity-dependent alternative splicing of Neurexin-1 in 
the central nervous system (CNS), a critical regulator of synaptogenesis 
(Iijima et al., 2011). Notably, previous studies have documented a role of 
several splicing factors in the biogenesis of selected miRNAs. For example, 
the splicing factor hnRNPA1 has been implicated in the production of miR-18a 
(Guil and Caceres, 2007) Similarly, the KH-type splicing regulatory protein 
(KSRP) has been shown to promote the biogenesis of only a subset of 
miRNAs, including let-7, by interacting with both DROSHA and DICER 
(Trabucchi et al., 2009). In this respect, SAM68 has been shown to play a role 
in the miRNA processing in chromatoid bodies during spermatogenesis 
(Messina et al., 2012). Notably, twelve miRNAs were found to be differentially 
expressed in wild type and Sam68 knockout germ cells, including miR-29b. 
Further, SAM68 interacts with both DROSHA and DICER in male germ cells, 
in a RNA-independent manner, suggesting a role of SAM68 in miRNA 
biogenesis.  
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Our results indicate SAM68 likely exerts its regulatory function at the 
transcriptional level. In line with our results, previous studies have implicated 
SAM68 in transcriptional regulation, mainly by acting as a competitive inhibitor 
of transcriptional activators. For example, interaction of SAM68 with hnRNPK, 
a RNA-binding protein involved in pre-mRNA processing, leads to the 
inhibition of hnRNPK function as a transcriptional activator (Yang et al., 2002). 
Additionally, SAM68 itself was identified as a potent transcriptional repressor 
that is independent of its RNA binding ability (Hong et al., 2002). SAM68 was 
further described to functionally interact with the CREB-binding protein (CBP), 
and negatively modulates its transcriptional activity. Finally, SAM68 has been 
shown to directly interact with RNA polymerase II in meiotic spermatocytes 
(Paronetto et al., 2011). Therefore, SAM68 binding to transcriptional 
coregulators and to RNA polymerase II itself points towards a role of SAM68 
in transcriptional regulation of gene expression.  
 
In line with this, we provide evidence that SAM68 negatively regulates the 
biogenesis of the miR-29 cluster, likely at the transcriptional level, as SAM68 
knockdown results in the up-regulation of primary miR-29a/b, as well as, 
precursor and mature miR-29b transcripts. Based on the aforementioned 
ability of SAM68 to interact with specific transcriptional regulators and 
modulate their activity, it is likely that SAM68 negatively regulates miR-29 
transcript levels by functionally interacting with miR-29 transcriptional 
regulators. A CCAAT-enhancer binding protein (C/EBP) binding site has been 
confirmed immediately downstream of the miR-29b-1/a transcription start site 
(TSS) (Eyholzer et al., 2010). This transcription factor is known to recruit CBP 
(Kovacs et al., 2003), an acetyl-transferase whose transcriptional activity can 
be modulated by SAM68 (Hong et al., 2002). Similarly, three nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-KB) binding sites have 
been characterized in the human miR-29b-1/a promoter located at -561, -110, 
and +134 relative to the TSS (Mott et al., 2011). Phosphorylated SAM68 has 
been shown to associate with NF-KB complexes in T-cell lymphoma cell line, 
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and facilitate binding to the NF-KB consensus motif (Fu et al., 2013). It is 
therefore likely that SAM68 mediates miR-29b-1/a transcriptional regulation 
via interaction with CBP and/or NF-KB.  
 
Importantly, SAM68 has the ability to link signal transduction pathways to 
downstream processes in response to phosphorylation and other post-
transcriptional modifications (Najib et al., 2005). Notably, SAM68 possesses a 
C-terminal domain rich in tyrosine residues, which are potential substrates for 
tyrosine kinases (Di Fruscio et al., 1999). For example, SAM68 can be 
phosphorylated by the extracellular signal-regulated kinase 1 (Erk1) (Matter et 
al., 2002), and lysine acetylated by CBP (Babic et al., 2004). Consistently, 
neuronal activity was found to induce SAM68 phosphorylation at serine 20 
(Iijima et al., 2011). This is highly relevant; especially as activity-dependent 
neuronal signal transduction is critical for the regulation of gene expression 
associated with LTM. Therefore, SAM68 function is likely to be modulated by 
phosphorylation upon neuronal activity.  
 
Therefore, SAM68 represents a key candidate factor for the activity-
dependent regulation of miR-29b owing to its potential to link neuronal to miR-
29b transcriptional regulation. Additional experiments are however required to 
validate this hypothesis. An important experiment in this regard could be 
checking miR-29b biogenesis and Tet3 gene expression after stimulation of 
hippocampal neurons from SAM68 knockdown mice. Furthermore, it would be 
of great interest to examine the role of SAM68 in cognitive processes. SAM68 
is abundantly expressed in different brain regions, such as the hippocampus, 
the cortex and the cerebellum (Grange et al., 2004; Iijima et al., 2011). 
However, very little is known regarding its function within the CNS. 
Interestingly, Sam68 knockout mice were shown to exhibit fewer spines on 
the dendrites of CA1 pyramidal neurons in the hippocampus (Klein et al., 
2013). Consistently, miR-29b overexpression reduces spine density in 
cultured hippocampal neurons (Lippi et al., 2011), suggesting that SAM68 
may be involved in dendritic spine structure via regulation of miR-29b. As 
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there is a strong interaction between dendritic spine density and memory 
acquisition in the hippocampus, SAM68 and miR-29b are likely involved in 
memory processes.  
 
Most importantly, we found that Sam68 is sensitive to TET3 levels as 
suggested by knockdown and overexpression experiments. This agrees with 
the observation that TET3 binding is targeted to genes involved in mRNA 
processing and splicing in neuronal cells (Jin et al., 2016). Importantly, Sam68 
was included in the list provided by the authors describing TET3 binding sites 
as revealed by ChIP sequencing. In addition, we observed that Sam68 
exhibits an expression pattern upon CFC opposite to Tet3 (data not shown). 
Based on these findings, we propose that increased TET3 levels negatively 
affect Sam68 gene expression, and this regulatory loop allows Tet3 transient 
expression upon neuronal activity.  
 
 
4.2 Conclusion  
 
Overall, these findings newly reveal the existence of a molecular cascade that 
involves the miR-29 cluster and the RNA-binding protein SAM68 in the 
regulation of the DNA demethylase TET3 (Fig. 4-1).  
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 Figure 4-1 Model for the regulation of Tet3 upon neuronal activity by its 
targeting miRNA, miR-29b and the RNA-binding protein SAM68. SAM68 
negatively modulates the transcriptional activity of the primary transcript miR-29b-
1/a (refer to Fig. 3-5), which ultimately leads to decreased expression in miR-29b 
levels (Fig. 3-2). Reduced level in miR-29b correlates with increased Tet3 levels 
(Fig. 3-1). MiR-29b likely facilitates Tet3 translation or fine-tunes its gene 
expression as it is able to binds to its 3’UTR and control its expression (Fig. 3-3). 
TET3 inhibits Sam68 expression (Fig. 3-S11) suggesting the existence of a 
feedback loop to allow Tet3 transient expression upon neuronal activity. 
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We propose a model by which SAM68 negatively regulates the transcriptional 
activity of miR-29b, likely via the interaction with transcription factors, which 
leads to alterations in miR-29b biogenesis. As a consequence, the expression 
of miR-29b-1/a primary transcripts is reduced, as well as, precursors and 
mature miR-29b. Decline in miR-29b expression creates a permissive 
environment for Tet3 translation and/or fine-tunes Tet3 gene expression. 
Consequently, increased Tet3 expression modulates activity-dependent gene 
transcription of targets related to synaptic plasticity and memory, such as 
Creb1 and Notch2. In contrast, the expression of Sam68, another target of 
TET3, is repressed, which keep Tet3 expression transient. 
 
The identification of molecular steps through which SAM68 regulates miR-29 
and TET3 are not only relevant for neuroscience but also for translational 
medicine. Consistently, loss of SAM68 function has been associated with the 
pathogenesis of the fragile X tremor/ataxia syndrome (FXTAS), a late onset 
neurodegenerative disorder characterized by ataxia and cognitive decline 
(Sellier et al., 2010). Consistently, Sam68 knockout mice have been reported 
to present motor-coordination deficits (Lukong and Richard, 2008). 
Interestingly, miRNA processing was reduced in patients with FXTAS (Sellier 
et al., 2013), and brain-specific knockdown of miR-29b resulted in an ataxic 
phenotype in mice (Roshan et al., 2014). This suggests that dysregulation of 
SAM68, thus miR-29b, could contribute to the pathogenesis of FXTAS. It 
would be of great interest to investigate whether or not TET3 expression and 
function are altered in FXTAS. In line with this idea, genome-wide alterations 
of 5hmC have been observed in the cerebellum of a FXTAS mouse model 
(Yao et al., 2014). Therefore, the findings of this thesis did not only reveal a 
yet unknown molecular cascade related to memory, but its alteration may 
underlie specific neurodegenerative disorders. 	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6.1 Abstract 	  
The brain is a highly heterogeneous organ composed of various neuronal and 
glial cells making it difficult to characterize cell-type specific epigenetic marks. 
Each brain cell-types are known to have distinct epigenetic signatures, which 
mediate cell-type specific regulation of gene expression. To overcome this 
problem, we optimized a method for the isolation of neuronal and non 
neuronal cells from murine brain tissue using a fluorescence-labeled anti-
NeuN antibody followed by flow cytometry. Isolated nuclei can be used for the 
analysis of epigenetic marks that decorate the DNA, such as 5-methylcytosine 
(5mC) and 5-hydroxymethylcytosine (5hmC). 	  	  
6.2 Introduction 
 
The goal of the protocol described below can be used to isolate individual cell 
types from brain tissue for subsequent analysis of epigenetic marks present at 
the DNA, including 5mC and 5hmC. This protocol relies on a specific antibody 
that selectively recognized mammalian neuronal nuclei (NeuN) named anti-
NeuN. Anti-NeuN antibody targets FOX3, a splicing factor present at nuclear 
speckles in neurons (Dent et al. 2010). Flurorescence-activated cell sorting 
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(FACS) is a novel technique in neuroscience to distinguish between neuronal 
from non-neuronal cells. To date, very few research groups have incorporated 
FACS in their studies for the analysis of epigenetic modifications, mainly 
because it is difficult to dissociate neural cells without causing cellular 
damage. In particular, adult brain tissues contain large amounts of connective 
tissue, which yield few viable cells. Here, we successfully developed a quick 
and efficient protocol for the isolation of neuronal nuclei from brain tissues that 
does not require ultracentrifugation.  
 
 
6.3 Methods 	  
Animals. C57Bl/6J mice were maintained under a reverse light-dark cycle in 
a temperature and humidity-controlled facility with food and water ad libitum. 
All experimental manipulations were performed during the animals' active 
cycle in accordance with guidelines and regulations of the cantonal veterinary 
office, Zurich. All behavioral tests were conducted in adult male animals by 
experimenters blind to treatment. 
 
Tissue collection. Immediately after sacrifice, the brain was removed and 
the hippocampus rapidly dissected on ice-cold Hank’s balanced salt solution 
(HBSS) without calcium and magnesium ions. Each hippocampus was minced 
with razor blades in approximately 1 mm thick sections and placed in a 15 mL 
conical centrifuge tube containing 1mL of cold HBSS.  
 
Tissue dissociation and immunolabeling of dissociated cells. HBSS was 
replaced with 0.5 mL Accutase (Millipore, L11-007) and directly incubated at 
37°C for 10 min in a waterbath. To stop the enzymatic digestion, 4 mL of 
Dulbecco’s modified eagle medium (DMEM) was added and tissues were 
dissociated with a fire-polished Pasteur pipette. Triturated tissues were 
centrifuged for 5 min at 500 rcf and the pellet was carefully resuspended in 
1mL HBSS. Cells were fixed with 4 mL of cold absolute ethanol (added drop-
wise) under gentle vortexation and kept at -20°C for 10 min. Cells were then 
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pelleted by centrifugation at 500 rcf for 5 min and re-hydrated with 5 mL HBSS 
for 15 min at room temperature. Fixed cells were pelleted again by 
centrifugation at 500 rcf for 5 min and finally resuspended in 0.5 mL HBSS. At 
this point, cells were transfered to a 2 mL eppendorf tube and incubated with 
anti-NeuN antibody conjugated to Alexa Fluor® 488 (Millipore, MAB377) 
diluted 1 :2000 in 0.1% NP-40, HBSS for 30 min at 4°C (end-over-end 
rotation). For the optimization of this protocol, cells were stained with 2 µl of 
propidium iodide (1 mg/mL in 0.1% NP-40) to evaluate cell viability for 15 min 
at room temperature. Then, cells were transfered in a 15 mL conical 
centrifuge tube and centrifuged at 500 rcf for 5 min. Following supernatant 
removal, the cell suspension was resusprended in 1mL HBSS, filtered through 
a cell strainer (previously soaked with HBSS) under centrifugation (100 rcf for 
5 seconds). All centrifugation steps until FACS were performed at 4°C. 
Flow cytometry. A FACS Aria (BD Biosciences) instrument was used for cell 
sorting, and FACS CantoII (BD Biosciences) instrument was used for analysis 
without sorting (flow cytometry facility of the University of Zurich). Sorted cells 
were always kept at 4°C and collected into low-binding microfuge tubes. 
NeuN-positive and NeuN-negative sorted cells were centrifuged at 300×g for 5 
min.  
 
DNA extraction. DNA was extracted from pellets using the AllPrep DNA/RNA 
Mini kit (Qiagen) according to manufacturer’s instructions. DNA concentration 
was determined using the Qubit® dsDNA High Sensitivity assay kit and 
Qubit® Fluorometer. 
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6.4 Results  	  
 
Dissociation of hippocampi.  
The dissociation of hippocampi was performed in an accutase solution, which 
contains a mixture of proteolytic and collagenolytic enzymes. The incubation 
period was optimized and set to 10 min, as this produced a high number of 
viable cells with minimal damages. Cells were subsequently triturated through 
Pasteur pipettes with tip fire-polished to an opening of 1 and 0.5 mm.  
 
Fixation and immunolabeling.  
As the anti-NeuN antibody recognizes an intracellular neuronal marker, both 
fixation and permeabilization of cells are crucial. To do so, we used 80% ice-
cold ethanol added in a drop wise manner while mixing gently on a vortex. 
This ensures fixation and minimizes the formation of cell clumps. Cells are 
fixed for 10 min at -20 °C. Fixed cells were incubated with an anti-NeuN 
antibody conjugated to Alexa Fluor® 488 at a dilution of 1 : 2000. Antibody 
dilution was optimized so that two distinct populations were distinguished : 
FITC-positive and FITC-negative. 
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Figure 6-1 a. Schematic protocol for the isolation of neuronal nuclei. b. 
Scatter plot showing distinct clusters for debris and cells (upper panel). Each 
dot represents one event detected by the laser. Forward scatter (FSC) 
represents size of the event; side scatter (SSC) represents granularity of the 
event. The box around cells indicates events that were “gated” for subsequent 
fluorescence analysis. Histogram represents the fluorescence signal for 
propidium iodide (PI) from fixed adult mouse hippocampus (lower panel). 
 
 
FACS analysis  
 
During FACS, single cells pass through the path of a laser; light passing 
through the sample (forward scatter: FSC) represents size of the event, and 
light reflected at a 90° angle (side scatter: SSC) represents granularity of the 
event. In a light scatter plot (Fig. 6-1), each dot represents one event (either a 
cell or piece of debris). Events of a similar type tend to cluster due to their 
unique property of FSC and SSC. To distinguish between cell bodies and 
debris, we took advantage of propidium iodide (PI), a fluorescent intercalating 
agent that can be used to stain DNA. After membrane permeabilization, PI 
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can easily penetrate cell membranes. Therefore, by measuring the emmitted 
flurorescence of PI, we can differentiate cell bodies from debris (Fig. 6-1). The 
gate was set in a FCS area/ SSC area dot plot that contains events 
corresponding to cell bodies (P1). The fraction containing cell bodies may 
contain cell doublets or clumps, which can affect the purity of the sorting. To 
select single cells only, a second gating step (P2) was performed in the FSC 
height versus FSC area. Events distributed along the diagonal are the single 
cells. To separate NeuN-positive from NeuN-negative cells, these events were 
further plotted according to their Alexa Fluro 488 (FITC)-area versus FSC-
area properties (Fig. 6-2).  
 
Two cell populations were distinguished : NeuN-positive and NeuN-negative 
cells, and each population were subsequently collected. We further examined 
sorted NeuN-positive and NeuN-negative cells with light microscopy and 
Figure 6-2 Flow cytometry analysis of neuronal nuclei dissociated from the 
mouse hippocampus using the neuron-specific antibody, NeuN conjugated to 
Alexa fluoro- 488 (FITC). Cells were first sorted based on their forward and side 
scatter from all possible events (left panel). This gate is called P1 (population 1). 
Next, single cells were sorted based on their size from the doublets or larger 
clumps of cells. This gate is called P2 (middle panel). Single cells were further 
gated as either non-neuronal cells (FITC neg) or neuronal cells (FITC pos) (right 
panel). 
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observed round cell bodies with few debris (data not shown). Typically, we 
obtained an average of 300 000 NeuN-positive cells and 260 000 NeuN-
negative cells per two hippocampal hemispheres. 	  
6.5 Discussion 	  
This FACS procedure has many potential applications in neuroscience. It 
could be valuable for separation of neuronal nuclei from other brain regions 
and may be applicable to other mammalian species. One major limitation 
concerns the relatively low yield of isolated cells, especially if the brain region 
analyzed is small in size. In this case, pooling of brain regions from a number 
of animals may be necessary. The use of the anti-NeuN antibody requires the 
fixation and permeabilization of tissue so that it can efficiently access the 
nucleus. During the fixation and permeabilization procedures, cell membranes 
are damaged, thus cytoplasmic RNAs and proteins can leak from the cell. 
This affects subsequent RNA extraction as only RNAs that remain in the 
nucleus will be quantifiable. Consistently, this protocol does not allow the 
isolation of proteins. Nevertheless, this protocol provides a simple and 
effective way to isolate neuronal from non-neuronal cells for subsequent 
analysis of DNA epigenetic modifications.  It can be easily used in 
combination  
6.6 Contributions  	  
E.A.K and L.v Z jointly developed and optimized this protocol. 
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7.1 Abstract 
 
Memory formation is a complex cognitive function regulated by coordinated 
synaptic and nuclear processes in neurons. In mammals, it is controlled by 
multiple molecular activators and suppressors, including the key signalling 
regulator, protein phosphatase 1 (PP1). Here, we  show that memory control 
by PP1 involves the miR-183/96/182 cluster and its selective regulation during 
memory formation. Inhibiting nuclear PP1 in the mouse brain, or training on an 
object recognition task similarly increases miR-183/96/182 expression in the 
hippocampus. Mimicking this increase by miR-183/96/182 overexpression 
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enhances object memory, while knocking-down endogenous miR-183/96/182 
impairs it. This effect involves the modulation of several plasticity-related 
genes, with HDAC9 identified as an important functional target. Further, PP1 
controls miR-183/96/182 in a transcription-independent manner through the 
processing of their precursors. These findings provide novel evidence for a 
role of miRNAs in memory formation and suggest the implication of PP1 in 
miRNAs processing in the adult brain. 
 
7.2 Contribution  
 
E.A.K designed and conducted experiments together with A.J which led to 
Figures 3 and 6b. 
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8.1 Abstract 
 
Cognitive decline in aging is a normal process that can become pathological 
and lead to dementia. Here, we show in mice that aged-related memory 
decline is caused by a defect in the biogenesis of the microRNA cluster miR-
183/96/182 resulting from an increase in protein phosphatase 1 (PP1), a 
potent memory suppressor. Correction of the defect restores normal memory 
in aged animals. Similar alterations in miR-183/96/182 and PP1 affect patients 
with TDP-43 pathologies. These results suggest a novel mechanism involving 
non-coding RNAs in cognitive disorders. 
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8.2 Contribution 
 
E.A.K conducted the environmental enrichment experiment used in Figures 1f 
and Supplementary Figure 8. E.A.K further designed/performed molecular 
cloning presented in Figures 2a, and Supplementary Figures 4 and 7. 
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9.1 Abstract 
 
The hippocampal formation is a brain structure essential for higher-order 
cognitive functions. It has exquisite differences in anatomical organization and 
cellular composition, and hippocampal sub-regions have different properties 
and functional roles. Areas CA1 and CA3 in particular, are key sub-regions for 
learning and memory formation that fulfill complementary but specific 
functions. The molecular basis for such specific properties and the link to 
learning and memory remain unknown. Here using a SWATH-MS proteomic 
approach and bioinformatic tools, we identify a selective proteomic signature 
in area CA1 and CA3, and reveal their specific dynamics during memory 
formation. We show that 30% of all quantifiable proteins are differentially 
expressed in area CA1 and CA3 at baseline, and that each proteome 
responds differently during the formation of memory for object or object 
location. Using clustering and cross-correlational analyses, we outline specific 
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temporal proteomic profiles and an increased correlation between both forms 
of memory within area CA1, but not within area CA3. These results provide 
new insight into a proteomic basis for hippocampal sub-region molecular and 
functional specificity.   
 
9.2 Contribution 
 
E.A.K performed behavioral experiments (object recognition) used in this 
study. 
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